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Friedreich’s ataxia (FRDA) is caused by the transcriptional silencing of the frataxin 
(FXN) gene. FRDA patients have expansion of GAA repeats in intron 1 of the FXN gene 
in both alleles. A number of studies demonstrated that specific histone deacetylase 
inhibitors (HDACi) affect either histone modifications at the FXN gene or FXN 
expression in FRDA cells, indicating that the hyperexpanded GAA repeat may facilitate 
heterochromatin formation. However, the correlation between chromatin structure and 
transcription at the FXN gene is currently limited due to a lack of more detailed analysis. 
Therefore, I analyzed the effects of the hyperexpanded GAA repeats on transcription 
status and chromatin structure using lymphoid cell lines derived from FRDA patients. 
Using chromatin immunoprecipitation and quantitative PCR, I observed significant 
changes in the landscape of histone modifications in the vicinity of the GAA tract in 
FRDA cells relative to control cells. Similar epigenetic changes were observed in GFP 
reporter construct containing 560 GAA repeats. Further, I detected similar levels of FXN 
 v 
pre-mRNA at a region upstream of hyperexpanded GAA repeats in FRDA and control 
cells, indicating similar efficiency of transcription initiation in FRDA cells.  I also 
showed that histone modifications associated with hyperexpanded GAA repeats are 
independent of transcription progression using the GFP reporter system. My data strongly 
support evidence that FXN deficiency in FRDA patients is consequence of defective 
transition from initiation to elongation of FXN transcription due to heterochromatin-like 
structures formed in the proximity of the hyperexpanded GAAs.
 vi 
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Chapter 1. Introduction and Background 
  
 
 
 
 
 
 
 
Some parts of this dissertation were modified from the following journal article. 
Eunah Kim, Marek Napierala, Sharon Y.R. Dent. Hyperexpansion of GAA repeats 
affects post-initiation steps of FXN transcription in Friedreich’s ataxia, Nucleic Acids 
Research, (2011) 39(19): 8366-8377. 
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1. FRDA 
Clinical and pathological aspects 
Friedreich’s ataxia (FRDA) is an degenerative neuro-muscular disease that affects 1 in 
50,000 individuals in the United States (Delatycki, Williamson and Forrest, 2000). The 
features of FRDA are recessively inherited with an incidence of one in 60 to 100 
depending on the ethnic group (Cossee, Schmitt, Campuzano, Reutenauer, Moutou, 
Mandel and Koenig, 1997). FRDA is characterized by progressive ataxia, including 
uncoordinated gait and limb movements, weakened muscle strength, and diminished 
senses of position and vibration. FRDA involves degeneration of the posterior columns of 
the spinal cord that is extended to the brain stem. FRDA patients also exhibit atrophy in 
the spinocerebellar tract, a set of axonal fibers in the spinal cord terminating in the 
cerebellum. In the dorsal root ganglion within the spinal cord, large primary sensory 
neurons are also degenerated in FRDA patients. Quantitative analysis reveals that contact 
between Purkinje cells in the cerebellum and dendrites are decreased, while the cerebellar 
cortex is not affected in patients of FRDA. These phenomena indicate that FRDA patients 
are most likely defective in providing information from the spinal cord through the 
spinocerebellar tract, which lead loss of position and vibration sense. Additionally, 
hypertropic cardiomyocytes are observed in approximately 80% of FRDA patients 
(Campuzano, Montermini, Lutz, Cova, Hindelang, Jiralerspong, Trottier, Kish, Faucheux, 
Trouillas, Authier, Durr, Mandel, Vescovi, Pandolfo and Koenig, 1997). Such 
cardiomyocytes contain abnormal intracellular iron deposits, suggesting that this feature 
of FRDA is associated with defective function of iron metabolism. 
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The role of FXN in mitochondria  
The FRDA disease gene is genetically mapped to chromosome 9q13 and encodes the 
Frataxin protein (FXN), a nuclear encoded mitochondrial protein (Campuzano, 
Montermini, Lutz, Cova, Hindelang, Jiralerspong, Trottier, Kish, Faucheux, Trouillas, 
Authier, Durr, Mandel, Vescovi, Pandolfo and Koenig, 1997; Campuzano, Montermini, 
Molto, Pianese, Cossee, Cavalcanti, Monros, Rodius, Duclos, Monticelli, Zara, 
Canizares, Koutnikova, Bidichandani, Gellera, Brice, Trouillas, De Michele, Filla, De 
Frutos, Palau, Patel, Di Donato, Mandel, Cocozza, Koenig and Pandolfo, 1996). FRDA is 
characterized by insufficient levels of FXN mRNA and protein in all examined tissues 
(Campuzano, Montermini, Lutz, Cova, Hindelang, Jiralerspong, Trottier, Kish, Faucheux, 
Trouillas, Authier, Durr, Mandel, Vescovi, Pandolfo and Koenig, 1997). Most functions 
of FXN have been demonstrated from yeast since yeast is viable without the yeast FXN 
homolog, Yfh1p, while FXN is an essential protein in mouse (Adinolfi, Iannuzzi, Prischi, 
Pastore, Iametti, Martin, Bonomi and Pastore, 2009; Bulteau, O'Neill, Kennedy, Ikeda-
Saito, Isaya and Szweda, 2004; Cossee, Puccio, Gansmuller, Koutnikova, Dierich, 
LeMeur, Fischbeck, Dolle and Koenig, 2000). Yfh1p plays a role in the storage of iron 
within mitochondria (Babcock, de Silva, Oaks, Davis-Kaplan, Jiralerspong, Montermini, 
Pandolfo and Kaplan, 1997). During iron homeostasis, FXN acts as a chaperone (Bulteau, 
O'Neill, Kennedy, Ikeda-Saito, Isaya and Szweda, 2004). Negatively charged FXN binds 
ferrous iron to balanced levels of iron (Dhe-Paganon, Shigeta, Chi, Ristow and Shoelson, 
2000). FXN has a ferroxidase activity when the concentration of ferrous iron is low in 
mitochondria leading to iron detoxification. Insufficient levels of FXN expression result 
in abnormal biosynthetic processes through a defective utilization of iron such as 
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decreased activities of iron-sulfur cluster (ISC) enzymes, accumulation of iron in 
mitochondria, and increased susceptibility to oxidative stress (Wilson, 2003). Oxidative 
stress is caused by oxygen excess in mitochondria due to an impaired ability to maintain 
homeostasis by detoxifying oxidative molecules. Decreased activity of ISC is associated 
with a dysfunction of respiratory chain leading to exacerbation of oxidative stress 
conditions (Jensen, Sanchez, Srinivasan, Valentine and Culotta, 2004). Oxidative stress 
observed in FRDA patient possibly results from FXN deficiency through impaired ISC in 
mitochondria. However, the underlying mechanisms of FRDA have not yet been fully 
elucidated. FXN is evolutionarily conserved from yeast to humans, in particular in the C-
terminal region. Interestingly, an exogeneous protein consisting of the C-terminus of 
human FXN fused to the N-terminus of Yfh1p complements the phenotype of Yfh1p 
deficient yeast (Wilson and Roof, 1997). Yfh1p precursor is processed to a 122-amino 
acid protein through cleavage by the mitochondrial processing protease (MPP) (Gordon, 
Shi, Dancis and Pain, 1999). Human FXN is similarly processed to a 128-amino acid 
protein from a 210-amino acid precursor. A N-terminal portion of FXN contains a 
mitochondrial signal sequence that is removed by the MPP. Unlike Yfh1p, FXN is 
processed through two-step cleavages (Schmucker, Argentini, Carelle-Calmels, Martelli 
and Puccio, 2008). The first cleavage occurs between Gly41 and Leu42 by MPP, 
generating a 169-amino acid intermediate protein in mitochondria. The second cleavage 
between Lys80 and Ser81 brings into being the 130-amino acid mature form of FXN. 
Only the final mature 130-amino acid form is functional in mitochondria. Ectopic 
expression of the mature form of FXN efficiently rescues the lethality of FXN null 
fibroblasts (Schmucker, Argentini, Carelle-Calmels, Martelli and Puccio, 2008). 
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Consistently, residues 90-210 of FXN have been demonstrated to be rigid by 
crystallography and NMR structure (Dhe-Paganon, Shigeta, Chi, Ristow and Shoelson, 
2000; Musco, Stier, Kolmerer, Adinolfi, Martin, Frenkiel, Gibson and Pastore, 2000). 
This suggests that C-terminal region of FXN is functional as mentioned above while N-
terminal region is responsible for localization of FXN into mitochondria. Indeed, residues 
90-210 correspond to an α1-helix and β1-sheet of the core structure of FXN that has 
potential to either function to donate iron to its partner or to form multimers (Dhe-
Paganon, Shigeta, Chi, Ristow and Shoelson, 2000). Although the processed forms of 
FXN are associated with FRDA pathology, it is noteworthy that defects in the process of 
FXN maturation are not. This emphasizes that enhancement of FXN transcription will be 
critical for curing FRDA. 
 
Differential expression of the FXN gene  
Since there is no evidence that FXN RNA is abnormally processed to make mature FXN 
RNA in FRDA, insufficient levels of FXN in FRDA likely result from the stage of FXN 
transcription. The FXN gene consists of 7 exons (Figure 1). The major transcripts contain  
exon 1 to 5a and are pronounced in all examined tissues of the patients (Kostrzewa, 
Klockgether, Damian and Muller, 1997). Other isoforms are occasionally detected in the 
heart. The FXN gene is differentially expressed in various tissues. The human FXN gene 
is mainly expressed in primary sites of degeneration in FRDA patients such as liver, heart 
and CNS, particularly in the spinal cord (Campuzano, Montermini, Molto, Pianese, 
Cossee, Cavalcanti, Monros, Rodius, Duclos, Monticelli, Zara, Canizares, Koutnikova, 
Bidichandani, Gellera, Brice, Trouillas, De Michele, Filla, De Frutos, Palau, Patel, Di 
Donato, Mandel, Cocozza, Koenig and Pandolfo, 1996). 
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Figure 1. Schematic diagram of the human FXN gene.  
Black bars represent exons (exon1, 2, 3, 4, 5a, and exon 5b). Light gray bar represents 
non-coding exon that is involved in regulating the expression of the gene and does not 
lead to additions to the protein sequence. Exons 5a and 5b are alternatives and result in 
slightly different protein sequences. Exon1~5a produce major FXN transcripts. The FXN 
gene is displayed in correct proportion. 
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Figure 1 
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The mouse FXN gene is differentially expressed during development. Expression is 
gradually increased from embryonic day 10 (E10) to later stages, appearing the highest at 
E14. In the spinal cord, a characteristic pattern of FXN expression becomes evident at 
E12.5, particularly in the thoracolumbar region that is most likely composed of large 
neuronal cells in the DRG (Jiralerspong, Liu, Montermini, Stifani and Pandolfo, 1997). In 
the adult brain, expression is restricted to the ependymal layer, chorid plexus, and 
granular layer of the cerebellum. This pattern indicates that FXN expression in various 
tissues is correlated with FRDA pathology, suggesting that changes in FXN transcription 
is likely responsible for FRDA. 
 
Mutation at the FXN gene in FRDA patients (Expansion of GAA repeats at 
the FXN gene in FRDA) 
Approximately 98% of FRDA patients are characterized by abnormal GAA repeat 
expansions within intron 1 of the FXN gene in both alleles (Figure 2), while 2% of FRDA 
patients have either point mutations or missense mutations in the FXN gene that act as 
null mutations (Bidichandani, Ashizawa and Patel, 1998; Campuzano, Montermini, 
Molto, Pianese, Cossee, Cavalcanti, Monros, Rodius, Duclos, Monticelli, Zara, 
Canizares, Koutnikova, Bidichandani, Gellera, Brice, Trouillas, De Michele, Filla, De 
Frutos, Palau, Patel, Di Donato, Mandel, Cocozza, Koenig and Pandolfo, 1996; Ohshima, 
Sakamoto, Labuda, Poirier, Moseley, Montermini, Ranum, Wells and Pandolfo, 1999). 
The GAA repeat at the FXN gene is detected in the middle of an Alu repeat element. In 
addition, a polymorphic mononucleotide tract of adenines (poly A tract) was identified in  
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Figure 2. Mutation of the FXN gene in FRDA patients. 
Expansion of GAA repeats is located within intron 1 of the FXN gene in FRDA patients. 
Black bars represent exon 1 and 2, while light gray bar represents non-coding exon 6. 
More than 1,700 GAA repeats are observed in FRDA patient, whereas less than 66 GAA 
repeats is detected in unaffected individuals. The region between exon 1 and exon 2 is 
displayed in correct proportion. 
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Figure 2 
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the vicinity of the GAA triplet repeat (Monticelli, Giacchetti, De Biase, Pianese, Turano, 
Pandolfo and Cocozza, 2004). Reduced levels of the FXN  
gene expression in FRDA patients are correlated with the hyperexpanded tract of 
repeated GAA triplets (Campuzano, Montermini, Molto, Pianese, Cossee, Cavalcanti, 
Monros, Rodius, Duclos, Monticelli, Zara, Canizares, Koutnikova, Bidichandani, Gellera, 
Brice, Trouillas, De Michele, Filla, De Frutos, Palau, Patel, Di Donato, Mandel, Cocozza, 
Koenig and Pandolfo, 1996; Grabczyk and Usdin, 2000a). In FRDA patients, the GAA 
tract frequently consists of more than 1500 triplets, whereas unaffected individuals have 
66 or fewer repeats at the FXN gene (Campuzano, Montermini, Molto, Pianese, Cossee, 
Cavalcanti, Monros, Rodius, Duclos, Monticelli, Zara, Canizares, Koutnikova, 
Bidichandani, Gellera, Brice, Trouillas, De Michele, Filla, De Frutos, Palau, Patel, Di 
Donato, Mandel, Cocozza, Koenig and Pandolfo, 1996; Pandolfo, 1998; Pianese, Turano, 
Lo Casale, De Biase, Giacchetti, Monticelli, Criscuolo, Filla and Cocozza, 2004). About 
85% of unaffected individuals have fewer than 12 GAA repeats whereas the remainder 
has 12 to 33 repeats.  
 
Expansion of the GAA triplet 
Expansion or contraction in size of the GAA repeat tracts is commonly observed during 
intergenerational transmission from parents to children. Although the underlying 
mechanism for how the size of the repeats is expanded has not yet been demonstrated, it 
has been suggested that DNA metabolism such as repair, replication, and recombination 
is involved in the flexibility of the GAA triplet size among generations. The mismatch 
repair (MMR) pathway is involved in inheritance and stability of the pathological repeats 
among generations (Krasilnikova, Kireeva, Petrovic, Knijnikova, Kashlev and Mirkin, 
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2007; Mirkin, 2007). In longer GAA repeats, single-stranded DNA is exposed to form 
hairpin DNA structures. MMR machinery is recruited to the hairpin structure, which 
leads to repeat expansion (Krasilnikova, Kireeva, Petrovic, Knijnikova, Kashlev and 
Mirkin, 2007). During DNA replication, exposed single stranded DNA containing GAA 
repeats enables folding into secondary DNA structures, which cause expansion of GAA 
repeats through misalignment of repetitive DNA (Ohshima and Wells, 1997). 
Recombination pathways also contribute to expansion of the GAA repeats. Longer GAA 
repeats are associated with a high frequency of recombination in E.coli, which results in 
expansion of the GAA repeats (Napierala, Dere, Vetcher and Wells, 2004). However, the 
detailed mechanisms are not clear.  
 
The effect of the GAA repeats on gene expression 
Previous studies demonstrate that the long GAA tracts cause transcriptional pausing in in 
vitro as well as in cell culture systems (Grabczyk and Usdin, 2000b; Krasilnikova, 
Kireeva, Petrovic, Knijnikova, Kashlev and Mirkin, 2007). Oligonucleotides containing 
longer GAA repeats show abnormal migration mobility on agarose gels when compared 
to linear DNA consisting of random sequences (Ohshima, Montermini, Wells and 
Pandolfo, 1998). Abnormal DNA structures of constructs containing longer GAA repeats 
have been observed by nuclear magnetic resonance (LeProust, Pearson, Sinden and Gao, 
2000). Polypurine/polypyrimidine DNA sequences containing mirror repeat symmetry 
form distinctive non-canonical structures. Either a pyrimidine or a purine rich single-
stranded DNA is intertwined into the major groove of a double helix consisting of the 
hyperexpanded GAA repeats forming intermolecular interactions between the strands in 
 13 
in vitro systems (Sakamoto, Chastain, Parniewski, Ohshima, Pandolfo, Griffith and 
Wells, 1999). Integration of oligodeoxyribonucleotides into longer GAA repeats block 
formation of the non-canonical DNA structure leading to restoration of full-length FXN 
transcripts in a concentration-dependent manner (Grabczyk and Usdin, 2000a). Small 
molecules recognizing specific DNA sequences such as polyamides de-repress FXN 
expression in cellular systems (Dervan and Edelson, 2003; Gottesfeld, 2007; Gottesfeld, 
Turner and Dervan, 2000). T7 RNA polymerase is impeded in the vicinity of GAA 
repeats in in vitro systems(Grabczyk and Usdin, 2000b). These results explain the 
correlation between size of the GAA repeats and defective transcription in FRDA. 
 
Treatments of FRDA 
Although the mechanism of how hyperexpanded GAA repeats down-regulate FXN 
expression in FRDA patient remains unclear, a number of studies have been carried out 
to identify compounds that enhance the expression of FXN in FRDA. To date, several 
compounds have been reported to increase FXN expression in cellular models, including 
hemin, butyric acid (Sarsero, Li, Wardan, Sitte, Williamson and Ioannou, 2003), and 
erythropoietin (Sturm, Stupphann, Kaun, Boesch, Schranzhofer, Wojta, Goldenberg and 
Scheiber-Mojdehkar, 2005) by unknown mechanisms.  
 
As FXN deficiency in FRDA results in increasing free radicals accompanied by abnormal 
accumulation of iron in mitochondria, both antioxidants and iron chelators have been 
applied to patients as a therapy to alleviate symptoms of FRDA. To date, only idebenone, 
a synthetic analogue of coenzyme Q10, has been demonstrated in a phase III trial as free 
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radical chelator (a treatment pipeline in the Friedreich's Ataxia Research Alliance 
(www.fara.org)). Unfortunately, a recent study has reported that idebenone does not 
improve neurological symptoms of FRDA in pediatric patients (Lynch, Perlman and 
Meier, 2010). 
 
Although the treatments mentioned above have improved the progress of FRDA, there 
are no effective treatments for curing FRDA. Enhancement of FXN expression from 
FXN cDNA harboring viral vectors partially alleviates FXN deficiency and defective 
response to oxidative stress (Fleming, Spinoulas, Zheng, Cunningham, Ginn, McQuilty, 
Rowe and Alexander, 2005; Gomez-Sebastian, Gimenez-Cassina, Diaz-Nido, Lim and 
Wade-Martins, 2007; Lim, Palomo, Mauritz, Gimenez-Cassina, Illana, Wandosell and 
Diaz-Nido, 2007). These studies suggest that restoring FXN levels is likely to be more 
effective for FRDA treatment than targeting downstream consequences of FXN 
deficiency. These studies make the point that understanding the underlying mechanisms 
of how FXN expression is affected by hyperexpanded tracts of GAA repeats in patients 
with FRDA is critical to developing therapeutic targets for curing FRDA. 
 
Models for study of FRDA  
As previously mentioned, an effective treatment has not yet developed for curing FRDA. 
Nevertheless, various systems have been applied to investigate the molecular pathology 
of FRDA. Each system has different purpose for study. 
 
• Escherichia coli (E.coli) 
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E.Coli has been used to investigate the propensity of longer GAA repeats to form non B-
DNA structures that are associated with abnormal replication and defective transcription 
in a length-dependent manner (Grabczyk and Usdin, 2000b). Moreover, persistent 
RNA_DNA hybrids in the presence of longer GAA repeats was first identified in E.coli 
(Grabczyk, Mancuso and Sammarco, 2007). RNA transcribed from long GAA repeats is 
hybridized with exposed single-stranded DNA to form persistent RNA_DNA hybrids, 
which inhibit transcription. Therefore, E.coli has been useful to define how non-B DNA 
structures consisting of longer GAA repeats act as cis-inhibitors of DNA metabolism. 
 
• Yeast 
Yeast is an appropriate model system to investigate the function of FXN since YFH1 
deficient yeast survive (Wilson and Roof, 1997). Moreover, similar to human and mouse 
FXN, yeast FXN homologue contains a potential mitochondrial targeting sequence in the 
N-terminus of YFH1. Therefore, deletion of YFH1 in yeast strain provided evidence to 
demonstrate that FXN acts as an iron chaperone in mitochondria (Babcock, de Silva, 
Oaks, Davis-Kaplan, Jiralerspong, Montermini, Pandolfo and Kaplan, 1997).  
 
• Mouse models 
Mouse models for FRDA have been generated to study the mechanism of the pathology 
and to test pharmacological therapies.  
o FXN null/conditional KO/inducible KO 
FXN null mice that have constitutive inactivation of FXN by homologous recombination 
are embryonic lethal, indicating that FXN is essential for development (Cossee, Puccio, 
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Gansmuller, Koutnikova, Dierich, LeMeur, Fischbeck, Dolle and Koenig, 2000). 
However, these mice did not exhibit defective iron metabolism during development, 
suggesting that lethality of the null embryos is independent of the iron metabolism 
defects caused. To further understand the lethality caused by knockout (KO) of FXN, 
conditional KO mice were generated using Cre-lox system specific to skeletal and cardiac 
muscle (Puccio, Simon, Cossee, Criqui-Filipe, Tiziano, Melki, Hindelang, Matyas, Rustin 
and Koenig, 2001). The conditional FXN KO mice were viable and resembled the 
phenotype of FRDA patients such as large sensory neuron dysfunction and deficient 
activity of mitochondria. Although this model did not exhibit susceptibility to oxidative 
stress, this phenomenon is also controversial in FRDA patients. This result suggests that 
the susceptibility to oxidative stress is not a major consequence of FXN deficiency. 
Therefore, these mice models that have insufficient levels of FXN without GAA repeats 
are appropriate to investigate the role of FXN and the pathological process of FRDA 
independent of the GAA repeats.  
o GAA in mice 
In an effort to define the effects of the GAA repeats in the pathology of FRDA, a 
transgenic mouse model (knock in-knock in (KIKI) mice) that contains a tract of GAA 
repeats was generated by insertion of 230 GAA into the first intron of the mouse Fxn 
gene and then mated with Fxn -/- mice (Miranda, Santos, Ohshima, Smith, Li, Bunting, 
Cossee, Koenig, Sequeiros, Kaplan and Pandolfo, 2002). The offspring (Fxn 230/-) have 
25~36% reduction of FXN expression relative to wild type. Unfortunately, these mice did 
not phenocopy a FRDA in despite of reduced levels of Fxn caused by the insertion of the 
GAA repeats. This finding suggests that 230 GAA repeats are insufficient to stimulate 
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pathology of FRDA. Moreover, this study also suggests that the appropriate location of 
the GAA repeat at a given gene might be a major factor in exhibition of FRDA 
pathology, as the location of the repeat in the mouse Fxn gene is not comparable to the 
location of the GAA repeats in human FXN gene. Nevertheless, this is a first FRDA 
mouse model to exhibit FXN deficiency caused by the presence of the GAA repeat.   
o YAC-GAA in mice 
To overcome embryonic lethality of FXN KO model, transgenic mice were generated by 
introducing 190 or 190/90 GAA repeats in intron 1 of the human FXN gene within a 
human YAC clone in the background of FXN null mice (Al-Mahdawi, Pinto, Ruddle, 
Carroll, Webster and Pook, 2004; Pook, Al-Mahdawi, Carroll, Cossee, Puccio, Lawrence, 
Clark, Lowrie, Bradley, Cooper, Koenig and Chamberlain, 2001). These transgenic mice 
exhibited typical FRDA phenotypes such as coordination deficits and a progressive 
decrease in motor activity in younger mice (3 month old), indicating that location of the 
GAA repeat is considerable when compared to KIKI mice. Histological studies in this 
model showed similarities to FRDA patients such as large vacuoles in dorsal root ganglia 
cells and iron deposits in cardiomyocytes, whereas electrophysiological studies showed a 
mild, progressive peripheral neuropathy (Al-Mahdawi, Pinto, Varshney, Lawrence, 
Lowrie, Hughes, Webster, Blake, Cooper, King and Pook, 2006). Moreover, this model 
showed tissue-specific and age-dependent somatic instability specifically in the 
cerebellum and dorsal root ganglia (Clark, De Biase, Malykhina, Al-Mahdawi, Pook and 
Bidichandani, 2007). Especially, a HDACi enhances FXN expression accompanying with 
increased levels of acetylation on histones in the KIKI mice. This outcome is meaningful 
that removal of marks associated heterochromatin-like structures has potential to alleviate 
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FXN deficiency in FRDA. However, it is unclear that the observed phenomenon resulted 
from the GAA repeats rather than from the construct per se.  
 
• Lymphoid cell lines 
Patient-derived lymphoid cell lines immortalized by Epstein-Barr virus available in the 
Coriell Institute (http://www.coriell.org). Moreover, cells from unaffected control 
individuals that contain a range of the GAA repeats are available for comparison studies. 
Therefore, the lymphoid cell lines are perhaps the best system to address my hypothesis 
since the presence of expanded GAA repeats at the FXN locus does not result in 
degeneration of these lymphoid cell lines. 
 
• The GFP_GAA system 
To avoid  effects from inherent characteristics of the FXN gene so that changes induced 
by the hyperexpanded GAA repeats per se can be determined, the GAA repeat derived 
from a FRDA patient (the GM16210 cell line from Coriell Institute) was engineered into 
an intronic region originating from the human Pem1 gene that is known to be spliced 
efficiently during RNA processing (Figure 3). The Pem intronic region containing the 
GAA repeat is embedded into the middle of the GFP coding region to divide the GFP 
coding region. The CMV promoter controls expression of this construct to avoid inherent  
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Figure 3. The GFP_GAA system. 
Schematic diagram of the GFP gene containing GAA repeats in the GFP_(GAATTC) 
reporter system. The GFP gene was divided into two exons (gray boxes) by the intron 
containing 560 GAA repeats. This reporter system is expressed under control of the CMV 
promoter (black box) and the tetracycline operator/repressor (TetO)2 (white boxes) that 
allows regulating transcription initiation by tetracycline. BGH pA represent bovine 
growth hormone and polyadenylation signal that is used during mRNA processing.  
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characteristics of the FXN promoter. A tetracycline operator element was also inserted in 
the promoter region so that GFP expression is regulated by tetracycline treatment, 
reducing the possibility of genomic instability associated with transcription of repetitive 
DNA sequences. This reporter construct genetically recapitulates the location of the GAA 
repeats as characteristics of the endogenous FXN gene. Moreover, the GFP_GAA system 
is validated as a model system to investigate molecular pathway associated with FXN 
expression changes (Soragni, Herman, Dent, Gottesfeld, Wells and Napierala, 2008). The 
insertion of the GAA repeats results in reduction of GFP mRNA. The intronic region in 
the proximity of the GAA repeat has increased histone modifications marking 
heterochromatin and decreased modifications marking euchromatin. Furthermore, small 
drugs that affect modifications on chromatin structure restore GFP expression in the 
GFP_(GAATTC) 560 cell line.  
 
Section 2 of this chapter will describe general information about epigenetics, which 
might play a role in down-regulating FXN transcription through the hyperexpanded GAA 
repeats in FRDA. 
 
    2. Epigenetics regulation of FXN expression 
In eukaryotes, the genome is organized into arrays of nucleosomes composed of histones 
and DNA. The histones are classified as H1, H2A, H2B, H3, and H4. Two copies of 
H2A, H2B, H3, and H4 compose a core octamer around which is wrapped around 146 
base pair (bp) DNA to form a nucleosome (Luger, Mader, Richmond, Sargent and 
Richmond, 1997). Chromatin is categorized into either euchromatin or heterochromatin, 
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depending on the conformation of structure, status of transcription, and post-translation 
modifications of histones. Configuration of chromatin structure is less packed in 
euchromatin. Moreover, transcription occurs more in euchromatin. In contrast, 
heterochromatin is characterized by condensed chromatin structure, rich in repetitive 
DNA, which is rarely transcribed in eukaryotes and plants (Grewal and Jia, 2007). 
Heterochromatin comprises most portions of both centromeres and telomeres in 
mammals. Genes localized in heterochromatin are most likely silenced (Grewal and Jia, 
2007). This phenomenon suggests that gene expression is regulated by not only trans 
through transcription machinery but also cis through organization of chromatin 
structures.  
 
Regulation of Chromatin structures 
• Post-translational modifications of Histones 
Regulation of chromatin structure is involved in various cellular functions such as 
DNA repair, replication as well as transcription by specific covalent marks in the N-
terminal tails of histones such as acetylation (ac) and methylation (me) (Li, Carey and 
Workman, 2007). Although a number of lysine residues have been identified as targets 
for modifications, this thesis will focus on well characterized sites of acetylation and 
methylation of histone H3 and H4 (Figure 4).  
 
Lysine residues in the amino-terminal regions of the histones are acetylated dependent on 
the status of transcription and on temporal and spatial conditions such as tissue specificity 
and development. Most acetylated histones are readily detected at transcriptionally active  
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Figure 4. Diagram of histone modifications at the amino-terminal tails of histone H3 
and H4 in each chromatin structure (euchromatin and heterochromatin). 
Each chromatin structure has distinct combination of histone modifications as shown in 
diagram. DNA wrapped around histone octamer consisting of pairs of H2A, H2B, H3 and 
H4. Each histone exhibits a flexible histone tail that can be dynamically modified. Shown 
here are histone modifications examined in this study. Blue oval represent a methyl group 
on lysine residue. Green oval represent acetyl group on lysine residue.  
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genes, particularly, in regulatory regions. Acetylation of lysines in histones neutralize the 
positive charge on histones and thereby decrease interactions between histones and  
DNAs. Therefore, transcription machinery is better able to access chromatin structures 
that are hyper acetylated. In contrast, lack of acetyl group on histone results in 
compaction of chromatin structure leading to gene silencing. Inhibition of histone 
deacetylation using HDACi is promising to enhance expression of a given gene. Indeed, 
many diseases such as neurodegenerative diseases and cancers have been treated with 
HDACi to alleviate symptoms through regulation of histone acetylation. In 
heterochromatin, acetylation is rarely detected as compared to euchromatin. Moreover, 
higher eukaryotic heterochromatin is associated with heterochromatin protein (HP1), first 
identified at pericentric heterochromatin in Drosophila.  HP1 contributes to formation 
and maintenance of heterochromatin by multimerization of HP1 through ‘chromo 
domain’ at the N-terminal and ‘chromo shadow domain’ at the C-terminal domain of the 
HP1. Gene silencing associated with HP1 is relived by inhibition of histone deacetylase, 
TSA, suggesting that hypoacetylation plays a role in HP1 mediated 
heterochromatinization. However, HP1 is also observed in euchromatin where genes are 
transcribed (Ayyanathan, Lechner, Bell, Maul, Schultz, Yamada, Tanaka, Torigoe and 
Rauscher, 2003), suggesting that additional proteins or histone modifications may be 
involved to HP1-mediated gene silencing. Acetylation of lysine of proteins can serve as 
binding sites for effector molecules that contain ‘bromodomains’. GCN5 is an 
acetyltransferase that is found in SAGA (Spt-Ada-Gcn5-acetyltransferase) complex. The 
GCN5 bromodomain-mediated interaction with acetylated histones promotes stability of 
SAGA complex at target genes, which maintain chromatin structure as euchromatin along 
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with increased levels of acetylation on histones. These results suggest a role of 
bromodomain as a modulator of chromatin modifying/remodeling complexes (Li and 
Shogren-Knaak, 2009).  
Methylation of histones is involved in either active or repressive chromatin structures, 
depending on either the number of methyl groups present on the targeted residue and 
which residue is targeted in the histones (Li, Carey and Workman, 2007). While 
acetylation occurs only at lysine residues, either lysine or arginine residues can be 
methylated. Methylation at lysine 9 of histone H3 is enriched in heterochromatin, while 
acetylation at lysine 9 of histone H3 is enriched in euchromatin, where genes are actively 
transcribed. Methylation at lysine 9 of histone H3 prevents acetylation, promoting gene 
silencing. Methylation at lysine 9 of histone H3 at heterochromatin provides a binding 
site for HP1 protein to stimulate condensing of chromatin structures through the chromo 
domain and chromo shadow domain (Jenuwein and Allis, 2001). HP1 at the region where 
H3K9me3 are enriched act as anchor to recruit chromatin-remodeling complex to further 
modify histones. Although the majority of H3K9me3 is associated with repressed and 
silenced regions throughout the genome, this histone modification is also found in the 
coding regions of transcriptionally active genes (Vakoc, Mandat, Olenchock and Blobel, 
2005). In centromeric heterochromatin, where gene expression is repressed, enrichment 
of H4K20me3 is accompanied by enrichment of H3K9me3 (Kourmouli, Jeppesen, 
Mahadevhaiah, Burgoyne, Wu, Gilbert, Bongiorni, Prantera, Fanti, Pimpinelli, Shi, 
Fundele and Singh, 2004; Schotta, Lachner, Sarma, Ebert, Sengupta, Reuter, Reinberg 
and Jenuwein, 2004).  
 
 27 
During development, genes are appropriately either turning on or off at a given stage. 
Methylation at lysine 27 of histone H3 is well-characterized and is important in the 
regulation of gene expression during development. H3K27me3 is mainly detected in 
repressive chromatin structures such as the inactive X chromosome as well as in 
inducible genes that are required for a given stage of development. In embryonic stem 
cells, H3K4me3 is co-localized with H3K27me3 at the promoter of some genes, called 
bivalent genes. The silenced gene expression at the bivalent gene is reversed by the 
removal of H3K27me3, and then H3K4me3 becomes pronounced for these genes as cells 
differentiate. To switch off gene expression, methylation of H3K4 is removed by a 
demethylase such as a lysine-specific demethylase (LSD) 1 leading to over representation 
of H3K27me3 at the bivalent gene during differentiation or development (Seenundun, 
Rampalli, Liu, Aziz, Palii, Hong, Blais, Brand, Ge and Dilworth, 2010). This 
phenomenon is also observed in non-developmental inducible genes such as a heat-shock 
gene, Hsp70, in Drosophila (Gilmour and Lis, 1986). RNA polymerase II (RNA pol II) 
are accompanying with H3K4me3 at the promoter. Once the repressive mark is removed, 
paused RNA pol II is released from the promoter to produce full-length transcripts. 
During on going transcription, H3K4me3 is mainly observed at the 5’ end of genes, 
representing initiation of transcription (Barski, Cuddapah, Cui, Roh, Schones, Wang, 
Wei, Chepelev and Zhao, 2007). The presence of H3K4me3 accompanying with H3S10p 
is preventing recruitment of a enzyme that methylases a lysine 9 of histone H3 as a 
repressive mark (Dormann, Tseng, Allis, Funabiki and Fischle, 2006). During elongating 
transcript, the lysine 36 of histone H3 are methylated by a Set domain containing 
methyltransferase that is recruited to an active form of RNA pol II phosphorylated at  
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Figure 5. Distribution of histone modifications across genes to define chromatin 
structures. 
This pattern is generated by genome scale screening by several groups of histone 
modifications in yeast and mammalian cells by ChIP-seq. The middle represents 
euchromatin that is enriched in H3K4me2/3 and H3K9ac at TSS of genes during 
transcription initiation and H3K79me2 and H3K36me3 in the body of genes during 
transcription elongation. Both ends represent heterochromatin that is compacted more 
than euchromatin as shown here. As I mentioned before, H3K9me3 and H4K20me3 are 
mainly enriched in heterochromatin.  
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distributed across genes and are associated with transcriptional status (Figure 5). This 
discrete enrichment of each histone modifications at a given gene suggests that 
coordination of histone modifications is essential for regulation of gene expression. 
 
• DNA methylation 
DNA methylation is an epigenetic event that is frequently observed in silenced gene 
expression. The C-5 position of cytosine is predominantly methylated in CG dinucleotide  
rich regions that are mainly located within regulatory regions such as gene promoters. 
These CG rich regions are generally unmethylated, but become methylated upon gene 
silencing. There are two possibilities to explain how DNA methylation is associated with 
gene silencing. First, during transcription, the accessibility of regulatory elements 
embedded into DNA sequences to either transcription machinery or transcription factors 
is inhibited by DNA methylation. Alternatively, there are proteins that specifically 
recognize methylated DNA such as the methyl-CpG-binding domain (MBD) containing 
protein, MeCP2. MBD proteins exist in mammals and bind to methylated CG residues in 
in vitro (Ng, Zhang, Hendrich, Johnson, Turner, Erdjument-Bromage, Tempst, Reinberg 
and Bird, 1999). Secondly, the methylated DNA may influence the configuration of 
chromatin structures. Indeed, high levels of DNA methylation affect the preference of 
histones to incorporate into certain DNA sequence in in vitro (Davey, Pennings and 
Allan, 1997).  
Interaction between histone methyltransferase and DNA methyltransferase supports that 
DNA methylation is associated with configuration of chromatin structure (Cedar and 
Bergman, 2009). In embryonic stem cells, SUV39H1 and SUV39H2 responsible for 
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H3K9me3 recruit DNA methyltransferase 3A and 3B to add methyl groups on CpG 
residues in satellite repetitive DNA (Lehnertz, Ueda, Derijck, Braunschweig, Perez-
Burgos, Kubicek, Chen, Li, Jenuwein and Peters, 2003). The methylated CpG is possibly 
recognized by MBD proteins, which recruit chromatin modifying/remodeling complexes 
leading to further heterochromatinization (Jones, Veenstra, Wade, Vermaak, Kass, 
Landsberger, Strouboulis and Wolffe, 1998). However, the relation between chromatin 
structures and DNA methylation in gene expression is not yet completely clear. 
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Suggested effect of the GAA repeats at the FXN gene leading to FXN 
deficiency in FRDA patients. 
Among various factors contributing to heterochromatin formation, high density of 
repetitive DNA, such as found in transposons, is a main stimulator across the genome 
(Grewal and Jia, 2007). Hyperexpanded GAA repeats have been reported to adopt a 
heterochromatin-like structure that is characterized by increased levels of di- and 
trimethylated lysine 9 of histone H3 (H3K9me2/3) and decreased acetylation on H3 and 
H4 at the FXN gene (Al-Mahdawi, Pinto, Ismail, Varshney, Lymperi, Sandi, Trabzuni 
and Pook, 2008; Rai, Soragni, Jenssen, Burnett, Herman, Coppola, Geschwind, 
Gottesfeld and Pandolfo, 2008; Saveliev, Everett, Sharpe, Webster and Festenstein, 2003; 
Soragni, Herman, Dent, Gottesfeld, Wells and Napierala, 2008). Inhibition of histone 
deacetylases restores levels of FXN expression in FRDA primary lymphocytes and in a 
murine model (Herman, Jenssen, Burnett, Soragni, Perlman and Gottesfeld, 2006; Rai, 
Soragni, Jenssen, Burnett, Herman, Coppola, Geschwind, Gottesfeld and Pandolfo, 2008), 
and manipulating histone modifications, particularly acetylation, can partially enhance 
expression of the FXN gene. Therefore, these studies suggest that changes in chromatin 
structure associated with the hyperexpanded GAA repeats induce FXN repression. 
However, it is an open question whether the heterochromatin-like structure induced by 
the hyperexpanded tract of GAA repeats impacts initiation and/or elongation of FXN 
transcription. Some studies show that the heterochromatin-like structure induced by the 
hyperexpanded GAA repeats impact promoter activity, which affect initiation of FXN 
transcription (De Biase, Chutake, Rindler and Bidichandani, 2009; Kumari, Biacsi and 
Usdin). Marks enriched in heterochromatin such as H3K27me3, H3K9me3 and 
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heterochromatin protein (HP1) are detected at the transcription start site (TSS) of the 
FXN gene in FRDA fibroblast lines, leading to the failure of FXN transcription initiation. 
These repressive marks may also influence expression of FXN antisense transcripts in the 
proximity of the TSS, thereby interfering with initiation of FXN sense transcripts in 
FRDA patients (De Biase, Chutake, Rindler and Bidichandani, 2009). Other studies 
suggest that both defective initiation and transcript elongation is affected in FRDA 
(Kumari, Biacsi and Usdin, 2011b). Levels of both H3K4me3, indicator of active 
transcription initiation at the TSS of the FXN gene and H3K36me3, an indicator of 
transcription elongation, are decreased at the FXN gene in FRDA cell lines. 
 
Besides altered histone modifications in the proximity of the hyperexpanded GAA 
repeats at the FXN gene in FRDA, high levels of DNA methylation have been reported in 
the region upstream of the GAA repeats in FRDA cell lines (Castaldo, Pinelli, Monticelli, 
Acquaviva, Giacchetti, Filla, Sacchetti, Keller, Avvedimento, Chiariotti and Cocozza, 
2008; Greene, Mahishi, Entezam, Kumari and Usdin, 2007). Moreover, the levels of 
DNA methylation correlate with the number of the GAA repeats (Castaldo, Pinelli, 
Monticelli, Acquaviva, Giacchetti, Filla, Sacchetti, Keller, Avvedimento, Chiariotti and 
Cocozza, 2008). Taken together, these observations suggest that epigenetic alterations 
induced by the hyperexpanded GAA repeats are associated with regulation of FXN 
expression in FRDA.  
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Current knowledge gap in molecular mechanisms to understand FXN 
deficiency via the hyperexpanded GAA repeats in FRDA patients. 
Epigenetic alterations caused by the hyperexpanded GAA repeats are one of the potential 
therapeutic targets for curing FRDA. Mouse models containing a longer GAA repeats 
tract exhibit sensitivity to epigenetic modifiers, suggesting that epigenetic regulation by 
the GAA repeats is likely a good target for potential drugs in restoring FXN expression 
(Festenstein, Sharghi-Namini, Fox, Roderick, Tolaini, Norton, Saveliev, Kioussis and 
Singh, 1999; Saveliev, Everett, Sharpe, Webster and Festenstein, 2003). Moreover, a 
number of studies showed that specific HDACi are capable of FXN expression and 
increasing histone acetylation in FRDA cells (Herman, Jenssen, Burnett, Soragni, 
Perlman and Gottesfeld, 2006; Rai, Soragni, Jenssen, Burnett, Herman, Coppola, 
Geschwind, Gottesfeld and Pandolfo, 2008; Soragni, Herman, Dent, Gottesfeld, Wells 
and Napierala, 2008). In contrast, levels of H3K9me3, a repressive mark, observed in the 
proximity of the long GAA repeats are maintained upon HDACi treatment (Herman, 
Jenssen, Burnett, Soragni, Perlman and Gottesfeld, 2006; Rai, Soragni, Jenssen, Burnett, 
Herman, Coppola, Geschwind, Gottesfeld and Pandolfo, 2008). Moreover, FXN 
expression has no association with inhibition of H3K9 methylation using a small 
molecule in FRDA cells (Grabczyk and Usdin, 2000a). These results suggest that two or 
more epigenetic silencing pathways may be simultaneous involved in regulation of FXN 
expression. Additionally, although DNA methylation is one of major factors associated 
with gene silencing, investigations of how DNA methylation might be involved in FXN 
deficiency have been limited to date. Therefore, this thesis provides a detailed definition 
of the spectrum of chromatin structure changes associated with hyperexpanded GAA 
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repeats in order to further understand the molecular mechanisms underlying FXN 
deficiency in FRDA cells. 
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The purpose of this study is to determine whether the hyperexpanded 
GAA repeats foster epigenetic changes associated with the formation of 
heterochromatin-like structures leading to inhibition of FXN 
transcription in FRDA. 
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Chapter 2. Materials and Methods 
 
 
 
 
 
 
 
 
Some parts of this dissertation were modified from the following journal article: 
Eunah Kim, Marek Napierala, Sharon Y.R. Dent. Hyperexpansion of GAA repeats 
affects post-initiation steps of FXN transcription in Friedreich’s ataxia, Nucleic Acids 
Research, (2011) 39(19): 8366-8377. 
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Cells  
Lymphoid cell lines were purchased from NIGMS Human Genetic Cell Repository at 
The Coriell Institute for Medical Research, Camden, NJ, USA. I selected three cell lines 
derived from FRDA patients: GM15850 harboring two expanded alleles of approximately 
650 and 1030 GAA repeats; GM16798 harboring two expanded alleles of approximately 
750 and 1000 GAA repeats and GM16209 harboring approximately 800 GAA repeats on 
both alleles of the FXN gene. As controls, I also used three lymphoid cell lines 
(GM15851, GM03928 and GM05152) derived from healthy, unaffected individuals 
containing short GAA repeat tracts within a normal range. Lymphoid cell lines were 
grown in RPMI 1640 medium supplemented with 15% FBS, 100U/ml penicillin and 100 
µg/ml streptomycin at 37°C in 5% CO2. The GFP_GAA systems [GFP_(GAATTC)0 
and GFP_(GAATTC)560] were generated by integration of a tract of GAA repeats 
derived from the GM16210 affected cells as described previously (Soragni, Herman, 
Dent, Gottesfeld, Wells and Napierala, 2008). A DNA fragment harboring approximately 
560 GAA repeats was PCR amplified from genomic DNA isolated from the GM16210 
cell line (NIGMS Human Genetic Cell Repository at The Coriell Institute for Medical 
Research, Camden, NJ, USA) as described in (Soragni, Herman, Dent, Gottesfeld, Wells 
and Napierala, 2008). PCR product was cleaved by Bsu36I and BssHII endonucleases 
and the GAA repeat containing fragment was cloned into intron 1 (1.2Kbp from the 
exon1/intron1 junction) of the GFP gene of the pGFP_Int plasmid (Seluanov, Mittelman, 
Pereira-Smith, Wilson and Gorbunova, 2004; Wilson and Roof, 1997). Plasmids 
containing 0 and 560 GAA repeats were integrated by site-specific recombination into the 
genome of the HEK293Flp-InT-Rex cell line (Invitrogen). The use of identical sites of 
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integration for both GFP_(GAATTC)0 and GFP_(GAATTC)560 constructs allows 
direct comparison between cell lines and eliminates any potential bias resulting from 
random integration events in different chromosomal contexts. Integrants were selected 
using hygromycin (200 µg/ml); individual hygromycin-resistant colonies were isolated 
and analyzed for repeat size and GFP expression level. Correct splicing of the GFP 
mRNA was determined as described earlier (Campuzano, Montermini, Molto, Pianese, 
Cossee, Cavalcanti, Monros, Rodius, Duclos, Monticelli, Zara, Canizares, Koutnikova, 
Bidichandani, Gellera, Brice, Trouillas, De Michele, Filla, De Frutos, Palau, Patel, Di 
Donato, Mandel, Cocozza, Koenig and Pandolfo, 1996). All constructs were sequenced 
prior to as well as after establishing the stable cell lines. The GFP_GAA lines were 
selectively maintained in Dulbecco’s Modified Eagle’s Medium with 10% FBS, 100 
U/ml penicillin and 100 µg/ml streptomycin at 37°C in 5% CO2 supplemented with 
hygromycin (200 µg/ml) and blasticidin (5 µg/ml). To induce transcription of the GFP 
minigene in the GFP_GAA system, cells were treated with 0.1 µg/ml tetracycline for 24h.  
 
Polymerase chain reaction (PCR) 
The size of the hyperexpanded tract of GAA repeats in lymphoid cell lines were 
determined by conventional PCR using primers 2500F and 629 under previously 
described conditions (Campuzano, Montermini, Molto, Pianese, Cossee, Cavalcanti, 
Monros, Rodius, Duclos, Monticelli, Zara, Canizares, Koutnikova, Bidichandani, Gellera, 
Brice, Trouillas, De Michele, Filla, De Frutos, Palau, Patel, Di Donato, Mandel, Cocozza, 
Koenig and Pandolfo, 1996). The insertion of the GAA repeats at an intron of the GFP 
gene in the GFP_GAA system was detected by the conventional PCR using the primers 
 40 
listed in Table 1. The PCR products were analyzed on 0.8% agarose gels. To perform 
quantitative reverse transcriptase PCR (qRT-PCR), total RNAs from lymphoid cell lines 
and the GFP_GAA system were isolated using the RNeasy Mini Kit (Qiagen). DNase I 
(TURBO DNA-free; Ambion) was added to remove genomic DNA contamination from 
isolated RNAs. The qRT-PCR was conducted using the Power SYBR Green RNA-to-CT 
1-Step Kit (7500 Fast Real Time-PCR System, Applied Biosystems). As a control, 
reactions were also performed without reverse transcriptase to confirm a removal of 
genomic DNA. To calculate levels of FXN expression, the delta Ct value was generated 
by subtraction of the Ct value of GAPDH from the Ct value of either FXN mRNA or 4 
different region transcripts of each cell line. Levels of FXN mRNA from each cell line 
were normalized to the delta Ct of GM15851. For levels of FXN pre-mRNA expression, 
each delta Ct value of 4 different regions at the FXN gene was normalized to the delta Ct 
value of the region upstream of the GAA repeat from GM15851. All primers used in this 
study are listed in Tables 1 and 2. 
 
Chromatin immunoprecipitation (ChIP) 
ChIP was performed according to the EZ ChIP instructions (Upstate Biotechnology Inc.). 
Briefly, proteins and DNA were cross-linked with 1% formaldehyde for 10min (15min in 
the case of RNA pol II ChIP) at room temperature. The cross-linking reaction was 
quenched with 125mM glycine for 5min (10min in the case of RNA pol II ChIP). Whole 
lysates were prepared by using a cell lysis buffer (50mM Tris-HCl at pH8.0, 10mM 
EDTA, and 1% SDS) supplemented with protease inhibitor (Mini EDTA-free protease 
inhibitor cocktail, Roche) and sonicated to obtain 100 to 300 bp DNA fragments using a 
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Bioruptor Sonicator (Diagenode). The fragmented chromatin was diluted 10 times with 
dilution buffer (16.7mM Tris-HCl at pH8.0, 167mM NaCl, 1.2mM EDTA, 1.1% Triton 
X-100, and 0.01% SDS). The chromatin fragments were pre-cleared for 1h using Protein 
A agarose (Millipore) pre-blocked with BSA and salmon sperm DNA. The equivalent of 
5 x 106 (1 x 107 cells in the case of RNA pol II ChIP) cells was immunoprecipitated 
overnight with 5µg of antibodies recognizing histone modifications (15µg of RNA pol II 
antibody in the case of RNA pol II ChIP). For total histone H3 and H4, the equivalent of 
5 x 106 cells was immunoprecipitated with 3µg of antibodies recognizing histone H3 and 
H4 after estimating saturation point between antibody for antibody and antigen. The 
immunoprecipitates were immobilized on the pre-blocked protein A agarose beads for 1h. 
Subsequently, the beads were washed with buffers containing low salt, high salt, and 
LiCl, chromatin was eluted from the beads with elution buffer (100mM NaHCO3 and 1% 
SDS) at room temperature for 15min twice and subsequently subjected to the reverse 
cross-linking reaction using 5M NaCl at 65°C for at least 5h. The DNAs from chromatin 
complexes were isolated with Tris-EDTA buffer (80mM Tris-HCl at pH6.5, and 20mM 
EDTA) supplemented with Protienase K and RNase A at 37°C for 30min followed by 
42°C for 1h. DNA fragments were purified using phenol/chloroform extraction before 
quantitative real-time PCR (qPCR). The qPCR was conducted using the Power SYBR 
Green-CT Kit (7500 Fast Real Time-PCR System, Applied Biosystems). The qPCR was 
carried out as follows: 10 min at 94°C, 50 cycles of 30s at 94°C followed by 60s at 60°C. 
Since changes in nucleosome occupancy is associated with gene activation and gene 
silencing (Bryant, Prabhu, Floer, Wang, Spagna, Schreiber and Ptashne, 2008), it is 
worthy to notice that the changes of histone modifications (referred to as the “relative 
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fold over total H3”) determined by qPCR was analyzed by normalizing the quantity of 
the immunoprecipitated sample to the quantity of total histone H3 (total H4 in the case of 
H4K20me3) after normalization to inputs.  
 
Antibodies  
The antibodies used in this study were anti-rabbit IgG as a negative control (Cell 
Signaling), anti-total H3 (Cell Signaling or Active Motif) and anti-total H4 (Abcam), 
anti-H3K9/14ac (Upstate), anti-H3K4me2 (Active Motif), anti-H3K4me3 (Abcam or 
Active Motif), anti-H3K9me3 (Upstate or Active Motif), anti-H3K27me3 (Abcam), anti-
H3K36me3 (Upstate), anti-H3K79me2 (Upstate or Active Motif), anti-H4K20me3 
(Active Motif), and an antibody against the large subunit of RNA polymerase II (N20; 
Santa Cruz Biotechnology). 
 
D-ribofuranosylbenzimidazole (DRB) treatments 
To optimize condition of DRB treatments in the lymphoid cell lines, various 
concentration, 1, 50, and 100 µM of DRB was applied to 1 x 106 cells for 5 hr. H3K4me3 
distribution was determined using ChIP assay upon inhibition of transcription elongation 
by DRB in the lymphoid cell lines as described in the ChIP section of Materials and 
Methods. 
 
Statistics  
 43 
A 2-way analysis of variance followed by the Bonferroni post-hoc test were performed to 
determine the statistical significance of the results of qRT-PCR and ChIP analysis 
between unaffected and FRDA cell lines. 
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Table 1. Primers used for analyses in the GFP_GAA reporter system. 
 Primer (5’ to 3’) 
Forward CTTCCCTTTACACAACGTTTGGGTT 
Repeat 
Reverse GTACTGTTTGGATTCAGTGAGGGACT 
Forward GCGACGTAAACGGCCACAAGTT 
Ex1/Ex2 
Reverse ATGCCCTTCAGCTCGATGCGGT 
Forward GACGACGGCAACTACAAGACC 
Ex1/Int 
Reverse CTAGGACAAAGGTGCCTAAGACC 
Forward AATAGCCTCCTGACCACAGATCCTT 
Up 
Reverse CCATGTGACATCTAGCCCCGCA 
Forward CCCACAGGCCTGAAACACT 
Down 
Reverse TTCATGCGTGCTAGGGTAAA 
Forward CCCTAGCACGCATGAACC 
Int/Ex2 
Reverse ATGCCCTTCAGCTCGATGCGGT* 
* This primer is the same as the GFP Ex1/Ex2 reverse primer. 
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Table 2. Primers used for analyses in the lymphoid cell lines. 
 Primer (5’ to 3’) 
Forward CCTTGCAGACAAGCCATACA 
Ex3/Ex4 
Reverse GGTCCACTGGATGGAGAAGA 
Forward AGCACTCGGTTACAGGCACT 
In1Ex2 
Reverse GCCCAAAGTTCCAGATTTCC 
Forward CGCATTTTATAAACAAGGCACA 
–242 
Reverse GTATGTGGGGCCAGGAGAC 
Forward CCCCACATACCCAACTGCTG Pro  
(or -133) Reverse GCCCGCCGCTTCTAAAATTC 
Forward AAGCAGGCTCTCCATTTTTG 
+48 
Reverse CCGCAGGCACTCTTCTGT 
Forward GAAACCCAAAGAATGGCTGTG Up  
(or +1231) Reverse TTCCCTCCTCGTGAAACACC 
Forward GGTACGCCGCATGTATTAGG 
+1394 
Reverse GCAACCAATCCCAAAGTTTC 
Forward CTGGAAAAATAGGCAAGTGTGG 
Down 
Reverse CAGGGGTGGAAGCCCAATAC 
Forward GGTAATCATGTTTTGGGTTTTGTGC 
In2Ex3 
Reverse AGTCCTCAAACGTGTATGGCTTGTC 
Number on the name of primers denotes the first base of forward primer on the target 
region with respect to the TSS, +1. 
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Chapter 3. Defining of chromatin structure in the vicinity of 
the hyperexpanded GAA repeats at the FXN gene 
 
 
 
 
 
 
 
Some parts of this dissertation were modified from the following journal article: 
Eunah Kim, Marek Napierala, Sharon Y.R. Dent. Hyperexpansion of GAA repeats 
affects post-initiation steps of FXN transcription in Friedreich’s ataxia, Nucleic Acids 
Research, (2011) 39(19): 8366-8377. 
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GAA repeat expansion and FXN deficiency in the lymphoid cell lines 
In order to discriminate lengths of the GAA repeats at the FXN gene in the lymphoid cell 
lines from unaffected (GM15851, GM03928 and GM05152) and FRDA patients 
(GM15850, GM16798 and GM16209), conventional PCR was carried out using a primer 
set that recognizes sequences surrounding where the GAA repeats at the FXN gene as 
previously reported (Campuzano, Montermini, Molto, Pianese, Cossee, Cavalcanti, 
Monros, Rodius, Duclos, Monticelli, Zara, Canizares, Koutnikova, Bidichandani, Gellera, 
Brice, Trouillas, De Michele, Filla, De Frutos, Palau, Patel, Di Donato, Mandel, Cocozza, 
Koenig and Pandolfo, 1996). A band around 500 bp is detected in unaffected controls, 
whereas FRDA lymphoid cell lines exhibit expanded GAA repeats up to 3Kbp (Figure 6). 
This pattern is consistent with number of the GAA repeats reported in NIGMS Human 
Genetic Cell Repository at The Coriell Institute for Medical Research as described in 
Materials and Methods.  
 
To confirm insufficient levels of FXN transcription in FRDA cell lines, FXN mature RNA 
was masured by qRT–PCR using a primer set recognizing exon 3 as a forward primer and 
exon 4 as a reverse primer (Figure 7). Clinically affected FRDA patients express as little 
as 5% and as much as 35% of FXN relative to unaffected individuals (Campuzano, 
Montermini, Molto, Pianese, Cossee, Cavalcanti, Monros, Rodius, Duclos, Monticelli, 
Zara, Canizares, Koutnikova, Bidichandani, Gellera, Brice, Trouillas, De Michele, Filla, 
De Frutos, Palau, Patel, Di Donato, Mandel, Cocozza, Koenig and Pandolfo, 1996; 
Pianese, Turano, Lo Casale, De Biase, Giacchetti, Monticelli, Criscuolo, Filla and 
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Cocozza, 2004). In order to establish a common epigenetic profile in FRDA cell lines, I 
selected three cell lines expressing low (GM16798), medium (GM15850), and high 
(GM16209) levels of the FXN mRNA corresponding to 8, 17 and 29% of the FXN 
mRNA found in the GM15851, respectively.  
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Figure 6. Hyperexpanded GAA repeats at the FXN gene in the lymphoid cell lines. 
Hyperexpanded tract of GAA repeats (indicated by the asterisk) was confirmed by 
conventional PCR in lymphoid cell lines derived from patients with FRDA but not in cell 
lines derived from unaffected individuals.  
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 Figure 6 
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Figure 7. FXN transcription is impaired in FRDA lymphoid cell lines. 
FXN mRNA was analyzed in 3 control and 3 FRDA cell lines by qRT-PCR with primers 
complementary to the exons 3 and 4. White bars designate control cell lines, while gray 
bars designate FRDA cell lines. Each cell line has different textures. FXN expression was 
normalized to the expression level determined for control GM15851 cells. The 
experiment was conducted in triplicate. All data are expressed as mean ± SD. Permission 
to re-use by Oxford University Press on behalf of the Nucleic Acids Research. 
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Distribution of histone modification at the FXN gene in the lymphoid 
cell lines 
To determine if the hyperexpanded GAA repeats might influence chromatin structures, 
chromatin immunoprecipitation (ChIP) was used to examine histone modifications in the 
lymphoid cell lines. Chromatin from the lymphoid cell lines was fragmented to obtain a 
majority of chromatin fragment under 500 bp (Figure 8). All six lymphoid cell lines, 
including three unaffected cells and three FRDA, were applied to examine each histone 
modification in the following text and figures. Additionally, to demonstrate that the 
hyperexpanded GAA repeats is sufficient to induce locally repressive chromatin 
structure, I took advantage of the GFP_GAA reporter system that is engineered to harbor 
560 GAA repeats at the GFP gene introduced into HEK293 cells. Each value in the ChIP 
experiments discussed below is represented as the relative fold over total H3 of DNA 
recovery against each histone modifications when normalized to total H3. Occupancy of 
total H3 is not affected by the presence of the hyperexpanded GAA repeats in either the 
lymphoid cell lines or the GFP_GAA system (Figure 9). 
 
H3K9/14ac 
To confirm the decreased levels of acetylation of histones at the FXN gene in FRDA 
observed in other reports, I performed ChIP for H3K9/14ac in the lymphoid cell lines. 
H3K9/14ac is well-known to be acetylated by GCN5 and p300/CBP-associated factor 
(PCAF), chromatin remodelers, in eukaryotes (Bhaumik, 2011). Four primer sets were 
used to define the distribution of H3K9/14ac at the FXN gene. I observed that the levels 
of H3K9/14ac, when normalized for nucleosomal occupancy, were decreased at the FXN  
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Figure 8. Fragmented chromatin extracted from the lymphoid cell lines and the 
GFP_GAA reporter system. 
Fragmented chromatin was detected using a 0.8% agarose gel. The majority of resulting 
fragmentation is between 100 and 500 bp in length. 
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Figure 8 
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Figure 9. Hyperexpanded GAA repeats have no association with distribution of total 
histone H3. 
Total histone H3 in lymphoid cell lines and the GFP_GAA reporter system was 
determined by ChIP. DNA from chromatin immunoprecipitated using antibodies specific 
for total histone H3 was subjected to qPCR using primers amplifying (A) promoter 
region, fragments upstream (Up) and downstream (Down) of the GAA repeats and 
junction between intron 2 and exon 3 (In2Ex3) in the lymphoid cell liens, and (B) 
Ex1/Int, a junction between exon 1 and the intron; Up, region upstream of the GAA 
repeats; Down, region downstream of the GAA repeats; Int1/Ex2, a junction between the 
intron and exon2 for the GFP_GAA reporter system. Total histone H3 levels are 
normalized to 1% of the input (5x106 cells). White bars designate control cell lines, while 
gray bars designate FRDA cell lines. Each cell line has different textures. No major 
differences of total histone H3 distribution are observed at the entire FXN gene in the 
lymphoid cell lines. 
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Figure 9 
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gene in FRDA cell lines as expected. Specifically the levels of H3K9/14ac were the 
lowest at the region upstream of the GAA repeats in FRDA cells when compared with 
unaffected cells (Figure 10). On the contrary, in promoter region of the FXN gene, the 
levels of H3K9/14ac were similar in both groups. This suggests that the hyperexpanded 
GAA repeats are associated with repressive chromatin structure, but this structure dose 
not extend to the promoter in FRDA cell lines. 
 
H3K9me3 
To add more evidence that the FXN gene in patients with FRDA has a repressive 
chromatin structure, I examined levels of H3K9me3 at the FXN gene by ChIP (Figure 
11). High levels of H3K9me3 are observed within heterochromatin such as is found at 
centromeres (Wang, Schones and Zhao, 2009). This methylation is most likely associated 
with silencing of gene expression. At the FXN gene, H3K9me3, when normalized for 
nucleosomal occupancy,  was greatly enriched in the region upstream of the GAA repeats 
where lower levels of H3K9/14ac were observed in FRDA cell lines.  
 
H4K20me3 
Although H3K9me3 is preferentially enriched at heterochromatin, this histone 
modification is also detected in the coding regions of transcriptionally active genes 
(Vakoc, Mandat, Olenchock and Blobel, 2005). In centromeric region, enrichment of 
H4K20me3 is accompanied by enrichment of H3K9me3  
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Figure 10. H3K9/14ac is significantly repressed at the FXN gene in FRDA cells. 
Distribution of H3K9/14ac at the FXN gene was defined by ChIP assay. DNA from 
chromatin immunoprecipitated using antibodies specific for H3K9/14ac was subjected to 
qPCR using primers amplifying promoter region, fragments upstream (Up) and 
downstream (Down) of the GAA repeats and junction between intron 2 and exon 3 
(In2Ex3). The experiment was conducted in triplicate using three FRDA and three 
control cell lines. Data are expressed as mean ± SEM. P values were calculated by 
comparing the averages of the relative fold over total H3 between unaffected and FRDA 
lines. Levels of H3K9/14ac was significantly decreased in at the region upstream of the 
GAA repeats in FRDA cells. Permission to re-use by Oxford University Press on behalf 
of the Nucleic Acids Research. 
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Figure 11. H3K9me3 is significantly increased at the FXN gene in FRDA cells. 
Distribution of H3K9me3 at the FXN gene was defined by ChIP assay. The ChIP 
experiment was conducted in triplicate using three FRDA and three control cell lines. 
Data are expressed as mean ± SEM. The region upstream of the GAA repeats in FRDA 
cells is enriched with levels of H3K9me3. Permission to re-use by Oxford University 
Press on behalf of the Nucleic Acids Research. 
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Figure 12. H4K20me3 is significantly increased at the FXN gene in FRDA cells. 
Distribution of H4K20me3 at the FXN gene was defined by ChIP assay. The ChIP 
experiment was conducted in triplicate using three FRDA and three control cell lines. 
Data are expressed as mean ± SEM. The region upstream of the GAA repeats in FRDA 
cells is enriched with levels of H4K20me3. Permission to re-use by Oxford University 
Press on behalf of the Nucleic Acids Research. 
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Figure 12 
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(Kourmouli, Jeppesen, Mahadevhaiah, Burgoyne, Wu, Gilbert, Bongiorni, Prantera, 
Fanti, Pimpinelli, Shi, Fundele and Singh, 2004; Schotta, Lachner, Sarma, Ebert, 
Sengupta, Reuter, Reinberg and Jenuwein, 2004). To ascertain whether high levels of 
H3K9me3 at the FXN gene in FRDA cells are associated with the heterochromatin-like 
structure induced by proximate regions of the hyperexpanded GAA repeats, I determined 
the status of H4K20me3 at the FXN gene in FRDA and control cell lines (Figure 12). The 
levels of H4K20me3, when normalized for nucleosomal occupancy, were the highest at 
the region upstream of the GAA repeats in FRDA cell lines. The results of ChIP 
experiments indicate that enrichment of H3K9me3 was associated with those of 
H4K20me3 at the region upstream of the hyperexpanded GAA repeats in FRDA cells. 
These data demonstrate that the region upstream of the hyperexpanded GAA repeats 
facilitate a heterochromatin-like structure in FRDA cell lines. 
 
H3K27me3 
Repressive chromatin structures, such as the inactive X chromosome and silenced 
inducible genes such as the bivalent gene, are frequently associated with enrichment of 
H3K27me3 (Plath, Fang, Mlynarczyk-Evans, Cao, Worringer, Wang, de la Cruz, Otte, 
Panning and Zhang, 2003; Seenundun, Rampalli, Liu, Aziz, Palii, Hong, Blais, Brand, Ge 
and Dilworth, 2010). To further define change of chromatin configuration in the presence 
of the hyperexpanded GAA repeats, I examined distribution of H3K27me3 at the FXN 
gene in the lymphoid cell lines (Figure 13). ChIP assay revealed over representation of 
H3K27me3, when normalized for nucleosomal occupancy, in the region upstream of the 
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GAA repeats in FRDA cell lines, co-localizing with both H3K9me3 and H4K20me3 
enrichment.  
 
Taken together, I found that the expansion of GAA repeats induces a particular 
constellation of histone modifications associated with heterochromatin-like structures at 
the FXN gene in FRDA cells. 
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Figure 13. H3K27me3 is enriched at the FXN gene in FRDA cells. 
Distribution of H3K27me3 at the FXN gene was defined by ChIP assay. The ChIP 
experiment was conducted in triplicate using three FRDA and three control cell lines. 
Data are expressed as mean ± SEM. The region upstream of the GAA repeats in FRDA 
cells is enriched with levels of H3K27me3. Permission to re-use by Oxford University 
Press on behalf of the Nucleic Acids Research. 
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Figure 13 
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Distribution of histone modification in the GFP_GAA reporter system 
To investigate whether the alteration of histone modifications at the FXN gene results 
from either inherent characteristics of the FXN gene or the hyperexpanded GAA repeats 
per se, I used a GFP_GAA reporter system that harbors a single copy of the GFP reporter 
gene containing 560 or 0 GAA repeats in the intron (Figure 14). I determined an effect of 
integrated tract of the GAA repeats on transcription using qRT-PCR. Mature RNA of 
GFP is decreased in the GFP_(GAATTC) 560 cells compared to the GFP_(GAATTC) 0 
cells under the tetracycline treatment (Figure 15), indicating that the GFP_GAA system 
genetically resembles FRDA.  
 
To assess changes in chromatin structures caused by presence of longer GAA repeats in 
the context of the GFP gene, I analyzed the distribution of histone modifications in the 
vicinity of the GAA repeats in the GFP_GAA reporter system. 
 
H3K9/14ac and H3K9me3 
In order to validate that chromatin structure flanking the hyperexpanded GAA repeats has 
characteristics of a heterochromatin-like structure, I examined distribution of H3K9/14ac 
as a mark for open chromatin (Figure 16) and H3K9me3 as a mark for closed chromatin 
in the GFP_GAA system (Figure 17). To further define whether the tract containing 560 
GAA repeats has ability to bidirectionally spread across the GFP gene as characteristics 
of heterochromatin, 2 more primer sets, a junction between exon1 and the intron and a 
junction between the intron and exon 2 were used to perform qPCR following  
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Figure 14. Validation of the presence of 560 GAA repeats in the GFP_GAA system. 
The presence of 560 GAA repeats in the GFP_GAA reporter system repeats was 
confirmed by conventional PCR. The region flanking 560 GAA repeats was amplified by 
primer sets, Up and Down for the GFP gene listed in Table 1. The GFP_(GAATCC) 560 
cells exhibit approximately 3Kb of PCR product, indicating that appropriate interstion 
and maintenance of 560 GAA repeats at the GFP gene in the GFP_(GAATCC) 560 cells.  
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Figure 15. GFP transcription is impaired in the GFP_(GAATCC) 560 cells. 
GFP mRNA was analyzed in the GFP_GAA reporter system with primers 
complementary to the exons 1 and exon 2. White bars designate control cell lines (the 
GFP_(GAATCC) 0 cells), while gray bars designate the GFP_(GAATCC) 560 cells. 
Each cell line has different textures. The experiment was conducted in triplicate. All data 
are expressed as mean ± SD. Asterisk indicates statistical significance (p < 0.05). The 
longer GAA repeats is associated with GFP deficiency in the GFP_(GAATCC) 560 cells. 
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immunoprecipitation of chromatin against each histone modification. I confirmed 
decreased levels of H3K9/14ac and increased levels of H3K9me3, when normalized for 
nucleosomal occupancy, in the vicinity of the GAA repeats at the GFP gene in the 
GFP_(GAATTC) 560 cells as shown in previous study (Soragni, Herman, Dent, 
Gottesfeld, Wells and Napierala, 2008). Furthermore, I observed that both H3K9/14ac 
and H3K9me3, when normalized for nucleosomal occupancy, extended up to the junction 
between exon 1 and the intron as well as the junction between the intron and exon 2 of 
the GFP gene in the GFP_(GAATTC) 560 cells. These results demonstrate that the 
introduced GAA repeat induces condensed chromatin structures in the proximity of the 
GAA repeats. Moreover, these results suggest that the hyperexpanded tract of GAA 
repeats per se has the ability to induce spreading of condensed chromatin structures. 
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Figure 16. H3K9/14ac is significantly decreased at the GFP gene in the presence of 
GAA repeats. 
Upon tetracycline treatment, the levels of H3K9/14ac in the GFP_GAA reporter system 
were determined by ChIP assay. White bars represent the GFP_(GAATTC) 0 cells. Gray 
bars represent the GFP_(GAATTC) 560 cells. Data are expressed as mean ± SEM. 
Asterisk indicates statistical significance (one: p < 0.05, two: p < 0.01, three: p < 0.001). 
The abundance of histone modifications is shown relative to input DNA in the PCR and 
normalized to a total H3 for each region. Levels of H3K9/14 are less enriched at the 
entire GFP gene in the GFP_(GAATTC) 560 cells relative to the GFP_(GAATTC) 0 
cells. Permission to re-use by Oxford University Press on behalf of the Nucleic Acids 
Research. 
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Figure 17. H3K9me3 is enriched at the GFP gene in the presence of longer GAA 
repeats. 
The levels of H3K9me3 in the GFP_GAA reporter system were determined in active 
transcription. White bars represent the GFP_(GAATTC) 0 cells. Gray bars represent the 
GFP_(GAATTC) 560 cells. Data are expressed as mean ± SEM. Asterisk indicates 
statistical significance (one: p < 0.05, two: p < 0.01, three: p < 0.001). The abundance of 
histone modifications is shown relative to input DNA in the PCR and normalized to a 
total H3 for each region. H3K9me3 are significantly increased in the GFP_(GAATTC) 
560 cells. Permission to re-use by Oxford University Press on behalf of the Nucleic Acids 
Research.
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Figure 17 
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Chapter 4. Determination of the effect of the GAA repeats in 
transcription in the context of chromatin structure 
 
 
 
 
 
 
 
Some parts of this dissertation were modified from the following journal article: 
Eunah Kim, Marek Napierala, Sharon Y.R. Dent. Hyperexpansion of GAA repeats 
affects post-initiation steps of FXN transcription in Friedreich’s ataxia, Nucleic Acids 
Research (2011) July. 
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In lymphoid cell lines 
FXN transcription in lymphoid cells 
In order to assess the effect of the hyperexpanded GAA repeats on the transcription 
progression at the FXN gene, I examined levels of FXN pre-mRNA in one upstream 
(from +1231 to +1344 within the intron 1) and in three regions downstream (variable 
positions, depending on repeat tract length) of the GAA repeats (Figure 18). Importantly, 
all primers pairs used in this experiment recognize FXN pre-mRNA to avoid a bias from 
the FXN mRNA. I found that levels of FXN pre-mRNA at the region upstream of the 
hyperexpanded GAA repeats have no differences in all three unaffected control cell lines 
and two of the three FRDA lymphoid cell lines. The GM16798 cell line exhibited a lower 
level of the FXN pre-mRNA upstream of the GAA repeats as compared to the remaining 
five cell lines. The GM16798 also exhibited the lowest expression of FXN mRNA 
(Figure 7). Additionally, FRDA patient from whom the GM16798 cell line was derived 
reported the earliest onset of the disease (5 yr vs. 10 and 11 yrs for the other FRDA 
individuals). In contrast to the similar levels of FXN pre-mRNA upstream of the GAA 
repeats, levels of FXN pre-mRNA downstream of the GAA repeats were reduced 
approximately 4-fold in all three FRDA lymphoid cell lines compared to unaffected cell 
lines. This result suggests that levels of the FXN pre-mRNA downstream expression are 
tightly associated with the pathology of FRDA. 
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Figure 18. FXN deficiency appears at the region downstream of the hyperexpanded 
GAA repeats in FRDA cells. 
Relative level of FXN pre-mRNA was determined in various regions of the transcript. 
One ‘Up’ and three ‘Down’ primers amplify regions in the immediate vicinity of the 
GAA repeats. In1Ex2 and In2Ex3 anneal to the junctions between the corresponding 
introns and exons of FXN pre-mRNA. White bars designate control cell lines, while gray 
bars designate FRDA cell lines. Each cell line has different textures. FXN pre-mRNA 
expression was normalized to the level of the fragment amplified upstream of the GAA 
region in the control GM15851 cells. The experiment was performed in triplicate. The 
region downstream transcript is significantly decreased in FRDA cells compared to 
unaffected cells. Permission to re-use by Oxford University Press on behalf of the 
Nucleic Acids Research. 
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Distribution of total RNA pol II at the FXN gene 
Gene expression is dependent on the accessibility of the DNA sequences to RNA 
polymerase, transcription factors, and chromatin remodeling complexes. In an effort to 
further investigate how the hyperexpanded GAA repeats influence progression of FXN 
transcription, I analyzed the distribution of total RNA pol II at the FXN gene by ChIP 
assay (Figure 19). Immunoprecipitation of total RNA pol II include both 
unphosphorylated and phosphorylated forms of the large subunit of RNA pol II. Seven 
primer sets were used to map the distribution of RNA Pol II in the FXN gene. Based on 
prior studies showing transcriptional pausing in the proximity of the long GAA tracts in 
in vitro and in cell culture system (Grabczyk and Usdin, 2000b; Krasilnikova, Kireeva, 
Petrovic, Knijnikova, Kashlev and Mirkin, 2007), I expected that RNA pol II progression 
would be inhibited in the region upstream of the GAA repeats, resulting in accumulation 
of transcriptional machinery in the region upstream of the GAA repeats in FRDA cell 
lines. However, I detected repressed levels of RNA pol II across the entire FXN gene in 
FRDA cell lines relative to unaffected cell lines. Importantly, levels of RNA pol II were 
not significantly changed at promoter region (from -242 to -12) in FRDA cell lines 
compared to unaffected cell lines, suggesting that FXN promoter activity is not affected 
in FRDA cell lines. These results correlate with similar levels of FXN pre-mRNA 
upstream of the GAA repeats observed in both FRDA and unaffected control cell lines as 
shown in Figure 17. 
 
Interestingly, RNA pol II is mostly enriched at a FXN promoter-proximal region (from 
+48 to +150) in unaffected cell lines, even though a number of the GAA repeats is short  
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Figure 19. Distribution of total RNA pol II is repressed at the FXN gene in FRDA 
cells. 
Level of total RNA pol II was determined by immunoprecipitating the large subunit of 
RNA pol II in FRDA and unaffected cells. Average occupancy of RNA pol II across the 
FXN gene in all three FRDA and three control cells is shown using gray circles and black 
squares, respectively. The position of the first nucleotide for the forward primer relative 
to transcription start site (TSS) is indicated below the X axis. The specificity of RNA pol 
II antibody for ChIP was verified by RNA pol II pausing at the +55 bp of the GAPDH 
gene. Error bars represent standard error of the mean. The experiment was conducted in 
triplicate using three FRDA and three control cell lines. The P value was generated by 
comparing the average % Input of total RNA pol II between unaffected and FRDA 
lymphoid cell lines. Permission to re-use by Oxford University Press on behalf of the 
Nucleic Acids Research. 
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in these cells. The accumulation at (+) 48 bp is significant as compared to either (-)242  
bp or (-)133 bp (p < 0.05). This phenomenon is also observed in some genes as shown at 
the GAPDH gene (Guenther, Levine, Boyer, Jaenisch and Young, 2007), where RNA pol 
II is known to pause. No RNA pol II Pausing was detected in the FRDA cell lines. These 
results suggest that defective transcriptional in FRDA cells originate at a post-initiation 
step of FXN transcription, which result in decreased enrichment of the transcription 
machinery at the promoter-proximal region as well as throughout the FXN gene. 
 
H3K4me2 and H3K4me3 
To investigate changes of active chromatin structure caused by the hyperexpanded GAA 
repeat, histone modifications relative to active chromatin structures was examined by 
ChIP in the lymphoid cell lines. As indicators of active transcription initiation, levels of 
both H3K4me2 and H3K4me3 exhibit a peak at transcription start site (TSS) of a given 
gene that is recently transcribed. Although H3K4me2 and H3K4me3 levels varied among 
lymphoid cell lines, levels of H3K4me2 and H3K4me3, when normalized for 
nucleosomal occupancy, were not changed at the promoter region (from –138 to –12) of 
the FXN gene in FRDA cell lines relative to unaffected controls (Figure 20 and Figure 
21). These results are correlated with our quantitative FXN pre-mRNA analyses showing 
similar levels of FXN pre-mRNA upstream of GAA repeats in both unaffected and FRDA 
cell lines. Interestingly, H3K4me2 and H3K4me3 were significantly diminished at a 
region upstream of the GAA repeats (from +1228 to +1344) of the FXN gene in FRDA 
cell lines, while levels of H3K4me2 and H3K4me3 cells, when normalized for 
nucleosomal occupancy, were increased at this region in the unaffected cells. Enrichment  
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Figure 20. H3K4me2 is decreased at the region upstream of the GAA repeat, not 
promoter region in FRDA cells. 
Distribution of H3K4me2 at the FXN gene was defined by ChIP assay. The ChIP 
experiment was conducted in triplicate using three FRDA (gray bars) and three control 
cell lines (white bars). Each cell line has different texture. Data are expressed as mean ± 
SEM. Levels of H3K4me2 are decreased at the region upstream of the GAA repeat in 
FRDA cell, while unaffected show great levels of H3K4me2. No differences of 
H3K4me2 were detected in both FRDA and unaffected cells. Permission to re-use by 
Oxford University Press on behalf of the Nucleic Acids Research. 
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Figure 21. Levels of H3K4me3 are not affected at promoter region in FRDA cells. 
Distribution of H3K4me3 at the FXN gene was defined by ChIP assay. The ChIP 
experiment was conducted in triplicate using three FRDA (gray bars) and three 
unaffected cell lines (white bars). Each cell line has different texture. Data are expressed 
as mean ± SEM. Levels of H3K4me3 are not changed at promoter region in FRDA cells 
compared to unaffected cells. However, H3K4me3 is decreased at the region upstream of 
the GAA repeats in FRDA cells compared to unaffected cells. Permission to re-use by 
Oxford University Press on behalf of the Nucleic Acids Research. 
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 Figure 21 
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of H3K4me2 has been associated with non-methylated CpG residues more tightly than  
transcriptional activity (Okitsu and Hsieh, 2007; Okitsu, Hsieh and Hsieh). In previous 
studies from other groups, increased levels of DNA methylation in the region upstream of 
the GAA repeats have been reported in FRDA cell lines relative to unaffected cells 
(Castaldo, Pinelli, Monticelli, Acquaviva, Giacchetti, Filla, Sacchetti, Keller, 
Avvedimento, Chiariotti and Cocozza, 2008; Greene, Mahishi, Entezam, Kumari and 
Usdin, 2007). Thus, the lower levels of H3K4me2 at the region upstream of the GAA 
repeats in FRDA cell lines could imply hyper DNA methylation, particularly at this 
region in FRDA patients. Enrichment of H3K4me3 in coding regions is associated with 
the efficient transition between initiation and elongation of transcription during ongoing 
transcription (Sims, Millhouse, Chen, Lewis, Erdjument-Bromage, Tempst, Manley and 
Reinberg, 2007). Therefore, the decreased levels of H3K4me3 in FRDA cell may reflect 
that the hyperexpanded GAA repeats influence the efficiency of post-initiation of FXN 
transcription.  
 
To further examine whether levels of H3K4me3 at the region upstream of GAA repeats 
in unaffected cells is associated with the activity of transcription elongation rather than 
transcription initiation, I measured levels of H3K4me3 upon inhibition of transcription 
elongation by D-ribofuranosylbenzimidazole (DRB) (Figure 22). DRB, a pharmacologic 
inhibitor of CDK9, decreases RNA pol II phosphorylation at Serine-2, a hallmark feature 
of the elongating form of RNA pol II during transcription. Following DRB treatment, the 
control cell line (GM15851) exhibited a significant decrease of H3K4me3 at the region 
upstream of the GAA repeats, which was very similar to that observed in FRDA cell line  
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Figure 22. H3K4me3 at the region upstream of the GAA repeats in FRDA cells is 
associated with impared FXN transcription elongation.  
H3K4me3 distribution were determined by ChIP assay upon inhibition of transcription 
elongation (50 µM DRB for 5 hr). The ChIP experiment was conducted in twice using 
one FRDA cell (gray bars: GM15850) and one unaffected cell line (white bars: 
GM15851). Data are expressed as mean ± SEM. H3K4me3 is decreased at the region 
upstream of the GAA repeats in FRDA cells upon inhibition of transcription elongation. 
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(GM15850), when normalized for nucleosomal occupancy. This result suggests that the 
levels of H3K4me3 at the region upstream of the GAA repeats are associated with 
transcription elongation rather than transcription initiation. Taken together, these results 
suggest that the hyperexpanded GAA repeat does not affect chromatin structures at the 
FXN promoter region but does result in impaired elongation of FXN transcription in 
FRDA. 
 
H3K36me3 and H3K79me2 
To further understand the effect of the hyperexpanded GAA repeats on the transcription 
process throughout the FXN gene, I examined the levels of H3K36me3 and H3K79me2, 
indicators of transcription elongation (Figure 23 and Figure 24). Increasing enrichment of 
H3K36me3 to the 3’-end of a gene is indicating ongoing transcription elongation. In 
unaffected cell lines, H3K36me3 levels, when normalized for nucleosomal occupancy, 
progressively increased toward the 3’-end of the FXN gene. However, enrichment of 
H3K36me3 was repressed across the FXN gene in FRDA cell lines. The distribution of 
H3K36me3 is consistent with total RNA pol II progression shown in Figure 19. These 
results indicate defective transcription elongation of the FXN gene in FRDA cell lines. A 
genome-wide study revealed that enrichment H3K79me2 at regions downstream of the 
TSS accompanying with H3K4me3 at the TSS is associated with full-length transcripts of 
genes (Kanhere, Viiri, Araujo, Rasaiyaah, Bouwman, Whyte, Pereira, Brookes, Walker, 
Bell, Pombo, Fisher, Young and Jenner, 2010). In contrast, enrichment of H3K4me3 
alone is feature for genes that experience transcription initiation alone, without elongation 
(Rahl, Lin, Seila, Flynn, McCuine, Burge, Sharp and Young, 2010). I found that 
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H3K79me2, when normalized for nucleosomal occupancy, were dramatically decreased 
throughout the FXN gene in FRDA cells, while H3K79me2 is pronounced in the vicinity 
of the GAA repeats in the unaffected control cells. As shown in Figure 20, since 
enrichment of H3K4me3 has no differences at the FXN promoter region in FRDA cell 
lines compared to unaffected cells, these results further support the that FXN deficiency 
in FRDA cells results from defective elongation step of FXN transcription after 
successful initiation. 
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Figure 23. H3K36me3 are repressed at the entire FXN gene in FRDA cells relative 
to unaffected cells. 
Distribution of H3K36me3 at the FXN gene was defined by ChIP assay. The ChIP 
experiment was conducted in triplicate using three FRDA (gray bars) and three 
unaffected cell lines (white bars). Each cell line has different texture. Data are expressed 
as mean ± SEM. Levels of H3K36me3 are decreased at the entire FXN gene in FRDA 
cells, while they are gradually increased toward 3’ end of the FXN gene in unaffected 
cells. Permission to re-use by Oxford University Press on behalf of the Nucleic Acids 
Research. 
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Figure 24. H3K79me2 is significantly decreased in FRDA cells. 
Distribution of H3K79me2 at the FXN gene was defined by ChIP assay. The ChIP 
experiment was conducted in triplicate using three FRDA (gray bars) and three 
unaffected cell lines (white bars). Each cell line has different texture. Data are expressed 
as mean ± SEM. Levels of H3K79me2 are decreased at the entire FXN gene in FRDA 
cells, while they are enriched in the vicinity of the GAA repeats at the FXN gene in 
unaffected cells. Permission to re-use by Oxford University Press on behalf of the 
Nucleic Acids Research. 
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In the GFP_GAA system 
H3K4me3 and H3K79me2 
To further investigate the effect of the presence of the GAA repeats in progression of 
transcription independently of FXN promoter or FXN intronic sequences, I examined 
enrichments of H3K4me3 (transcription initiation) and H3K79me2 (transcription 
elongation) at the GFP gene in the GFP_GAA reporter system using ChIP assay when 
normalized for nucleosomal occupancy (Figure 25 and Figure 26). Levels of H3K4me3 
were not changed at the region upstream of the GAA repeats including a junction 
between exon 1 and the intron and the region upstream of the GAA repeats (named ‘Up’) 
in the GFP_(GAATTC) 560 cells compared to the GFP_(GAATTC) 0 cells that lack the 
GAA repeats. However, H3K4me3 levels were significantly decreased in the region 
downstream of the GAA repeats in the GFP_(GAATTC) 560 cells. This distribution of 
H3K4me3 at the GFP gene in GFP_(GAATTC) 560 cells is comparable to that found at 
the FXN gene in the FRDA cell lines. In addition, I found that enrichment of H3K79me2 
was significantly decreased at the region downstream of the GAA repeats at the GFP 
gene in the GFP_(GAATTC) 560 cells when compared to the corresponding region in the 
GFP_(GAATTC) 0 cells. These results clearly show that the presence of the 
hyperexpanded GAA repeats not only stimulate epigenetic changes in the proximate 
chromatin independently of the DNA context, but also are sufficient to impede 
transcription elongation. More importantly, the observations of histone modification 
showing impediment of transcription elongation in the GFP_(GAATTC) 560 cells, 
without affecting initiation, is consistent with alteration of histone modifications  
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Figure 25. H3K4me3 is affected at the region downstream of the GAA repeats in the 
presence of the GAA repeats. 
The levels of H3K4me3 in the GFP_GAA reporter system were determined by ChIP 
assay. White bars represent the GFP_(GAATTC) 0 cells. Gray bars represent the 
GFP_(GAATTC) 560 cells. Data are expressed as mean ± SEM. Asterisk indicates 
statistical significance (p < 0.05). The abundance of histone modifications is shown 
relative to input DNA in the PCR and normalized to a total H3 for each region. Upon 
tetracycline treatment, H3K4me3 are affected at the region downstream of the GAA 
repeats in the GFP_(GAATTC) 560 cells compared to the GFP_(GAATTC) 0 cells. 
Permission to re-use by Oxford University Press on behalf of the Nucleic Acids 
Research. 
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Figure 26. H3K79me2 is affected at the region downstream of the GAA repeats in 
the GFP_(GAATTC) 560 cells. 
The levels of H3K79me2 in the GFP_GAA reporter system were determined by ChIP 
assay. White bars represent the GFP_(GAATTC) 0 cells. Gray bars represent the 
GFP_(GAATTC) 560 cells. Data are expressed as mean ± SEM. Asterisk indicates 
statistical significance (one: p < 0.05, three: p < 0.001). The abundance of histone 
modifications is shown relative to input DNA in the PCR and normalized to a total H3 for 
each region. Upon tetracycline treatment, H3K79me3 are decreased at the region 
upstream of the GAA repeats in the GFP_(GAATTC) 560 cells compared to the 
GFP_(GAATTC) 0 cells. Permission to re-use by Oxford University Press on behalf of 
the Nucleic Acids Research. 
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observed in FRDA cell lines. These results strongly suggest that elongation is the major 
step hampered by the hyperexpanded GAA repeats in FRDA patients.  
 
Longer GAA repeats is associated with inhibiting progression of RNA polymerases in in 
vitro and in vivo systems (Grabczyk and Usdin, 2000b; Krasilnikova, Kireeva, Petrovic, 
Knijnikova, Kashlev and Mirkin, 2007). Moreover, transcription arrest is associated with 
alteration of histone modifications (Balakrishnan and Milavetz, 2007; Li, Carey and 
Workman, 2007; Nagata, Ito, Arimitsu, Koyama and Sekimizu, 2009). To assess whether 
RNA pol II arrest associated with the presence of the GAA repeats can prompt the 
cascade of silencing events, I used the GFP_GAA reporter system allowing us to 
precisely control initiation of transcription using tetracycline regulated operator/repressor 
(Figure 27). Generally, the GFP_GAA reporter system has been cultured in the absence 
of tetracycline to maintain cell lines. Both the GFP_(GAATTC) 560 and the 
GFP_(GAATTC) 0 cells were sub-cultured for less than 10 passages prior to the 
tetracycline treatment. In order to investigate the effect of transcription in alteration of 
histone modifications by the hyperexpanded GAA repeats, the cells were prepared in 
parallel in the absence or presence of the tetracycline. Upon the absence of tetracycline to 
inhibit transcription, levels of H3K9me3 were pronounced in regions both upstream and 
downstream of the GAA repeats in the GFP_(GAATTC) 560 cells, not the 
GFP_(GAATTC) 0 cells. After initiation of transcription by the tetracycline treatment, 
no significant changes of H3K9me3 levels were observed in the proximity of the GAA 
repeats in the GFP_(GAATTC) 560 cells when compared to the GFP_(GAATTC) 560 
cells that is not treated with tetracycline. However, enrichments of H3K79me2 were 
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dramatically reduced at the region downstream of the GAA repeats in the 
GFP_(GAATTC) 560 cells upon inhibition of transcription as I expected. This result 
strongly suggests that the hyperexpanded GAA repeats per se are the underlying cause of 
the heterochromatin-like structure formation and the arrest of RNA pol II is unlikely to 
serve as a signal instigating epigenetic changes associated with the longer GAA repeats. 
Taken together, my results demonstrate that insufficient levels of FXN expression in 
FRDA patients are a consequence of impeded transcription elongation through the 
heterochromatin-like structure induced by the hyperexpanded GAA repeats. 
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Figure 27. The tract of GAA repeats is sufficient to form the heterochromatin-like 
structure in the absence of transcription, which lead to inhibition of transcription 
elongation. 
Effect of transcription on the formation of the heterochromatin-like structure was 
analyzed using ChIP assay in the GFP_GAA reporter system. Enrichment of H3K9me3 
and H3K79me2 at the region upstream (Up) and the region downstream (Down) were 
determined in the absence and presence of tetracycline (0.1 µg/mL for 24 h). White bars 
represent results obtained from cell line lacking the GAA repeats in intron of the GFP 
gene while gray bars representing cells harboring intronic 560 of GAAs. Data are 
expressed as mean ± SEM. The experiment was conducted in triplicate and P values were 
calculated from the average of all three determinations for the GFP_(GAATTC) 560 and 
the GFP_(GAATTC) 0 cells. H3K9me3 is enriched in the GFP_(GAATTC) 560 in the 
absence and presence of tetracycline. H3K79me2 are impaired in the GFP_(GAATTC) 
560 upon tetracycline treatment to resume transcription. Permission to re-use by Oxford 
University Press on behalf of the Nucleic Acids Research. 
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Chapter 5. Discussion 
 
 
 
 
 
 
 
 
 
 
Some parts of this dissertation were modified from the following journal article: 
Eunah Kim, Marek Napierala, Sharon Y.R. Dent. Hyperexpansion of GAA repeats 
affects post-initiation steps of FXN transcription in Friedreich’s ataxia, Nucleic Acids 
Research, (2011) 39(19): 8366-8377. 
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In my study, defining altered histone modifications and repressive RNA pol II 
distribution at the FXN gene in FRDA cell lines provides strong evidence that FXN 
insufficiency in FRDA cell lines begin at a post-initiation step of FXN transcription. I 
also detected an accumulation of total RNA pol II at the promoter-proximal region of the 
FXN gene in unaffected cells, but not in FRDA cells. Several studies using genome-wide 
analysis have suggested that post-initiation events are rate-limiting to regulate 
transcription of some genes (Guenther, Levine, Boyer, Jaenisch and Young, 2007; 
Saunders, Core and Lis, 2006). This phenomenon is well-described for a heat shock–
inducible gene, Hsp70, in Drosophila (Gilmour and Lis, 1986). Increased levels of RNA 
pol II are observed at the promoter of the Hsp70 gene upon uninduced condition, and this 
RNA pol II is released from the promoter by heat shock stimuli, leading to launching of 
Hsp70 transcription (Gilmour and Lis, 1986). Genome-wide analysis of transcripts using 
nuclear run-on assay reveals paused Pol II on a large number of genes in human cells 
(Core, Waterfall and Lis, 2008). This phenomenon prompts me to hypothesize that FXN 
gene may be categorized as an inducible gene that is regulated by tissue-specific factors. 
The FXN gene is positively regulated by two transcription factors, peroxisome 
proliferator-activated receptor (PPAR) gamma and hypoxia-inducible factor-2 alpha 
(Marmolino, Acquaviva, Pinelli, Monticelli, Castaldo, Filla and Cocozza, 2009; Oktay, 
Dioum, Matsuzaki, Ding, Yan, Haller, Szweda and Garcia, 2007). PPAR gamma is more 
highly expressed in FRDA cells compared to unaffected individuals (Marmolino, 
Acquaviva, Pinelli, Monticelli, Castaldo, Filla and Cocozza, 2009). Imbalance of iron as 
detected in FRDA patients may also affect the induction of FXN expression, as proposed 
in a previous study (Li, Besse, Ha, Kovtunovych and Rouault, 2008). The longer GAA 
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repeats at the FXN gene in FRDA patient may recruit particular factors that inhibit 
induction of FXN expression. In contrast, non-B DNA structure adopted by the longer 
GAA repeat per se may inhibit to recruit particular factors that induce of FXN 
expression.  
 
According to my results, paused RNA pol II is unlikely to reflect ongoing transcription, 
at least at the FXN gene. Although   FXN pre-mRNA levels  are similar in both 
unaffected and FRDA cells, total RNA pol II, as measured by ChIP, only accumulates at 
the promoter-proximal region of the FXN gene in FRDA cells. Moreover, this 
accumulation is restricted to the promoter-proximal region, not other regions including 
promoter. Therefore, FXN pre-mRNA seems to reflect FXN promoter activity more than 
chromatin structure at the region   This finding is consistent with those of a previous 
study that indicated promoter activity is not affected at the FXN gene in FRDA cells, 
although altered histone modifications were observed at the promoter-proximal region 
(Kumari, Biacsi and Usdin, 2011b). In an effort to confirm correlation between the levels 
of RNA pol II and FXN transcription, I tried to measure pre-mature FXN RNA at the 
promoter-proximal region (+48bp). Unfortunately, the FXN promoter-proximal region is 
quite CG-rich, so that qRT-PCR assays were not successful. Both H3K4me2 and 
H3K4me3 are greatly decreased at this region in FRDA cells when compared to 
unaffected cells. This result suggests that the paused RNA pol II at the promoter-
proximal region in unaffected cells may facilitate chromatin remodeling for euchromatin 
as shown in my results to trigger additional transcription progression. The paused RNA 
pol II may help to stabilize the binding of transcription machinery assisting further 
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rounds of transcription initiation. Indeed, the accumulated RNA pol II in the promoter-
proximal region is associated with the enrichment of active histone marks such as 
H3K9/14ac and H3K4me3 in the human genome, regardless of transcription status 
(Guenther, Levine, Boyer, Jaenisch and Young, 2007). FRDA cells exhibit a slow rate of 
FXN mRNA synthesis when compared to unaffected cell lines (Punga and Buhler, 2010).  
 
The decreased levels of RNA pol II in the coding region of genes is associated with 
decreased levels of H3K4me2 and H3K4me3, hyper-methylated CpG residues, and 
increased levels of H3K9me (Okitsu and Hsieh, 2007; Okitsu, Hsieh and Hsieh, 2010). 
Consistently, levels of total RNA pol II is repressed in the region upstream of the GAA 
repeats in FRDA cells compared to unaffected cells. Moreover, the region upstream of 
the GAA repeats display less enrichment of H3K4me3 and H3K4me2 in FRDA cells 
compared to unaffected cells. Enrichment of H3K4me3 in the coding region of genes is 
associated with the efficiency of transition between initiation and elongation in 
transcription (Okitsu and Hsieh, 2007; Okitsu, Hsieh and Hsieh, 2010), and contributes to 
recruit chromatin-remodeling complexes (Li, Ilin, Wang, Duncan, Wysocka, Allis and 
Patel, 2006; Sims, Millhouse, Chen, Lewis, Erdjument-Bromage, Tempst, Manley and 
Reinberg, 2007). Therefore, the decreased levels of H3K4me3 at the region upstream of 
GAA repeats in FRDA cells may impair recruitment of chromatin-modifying complexes 
or lead to FXN deficiency resulting from impediment of FXN transcription elongation in 
FRDA patients.  
 
Histone methylation status represents both an important regulatory element of gene 
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expression and an indicator of the transcriptional status of a gene. Enzymes that add or 
remove methyl groups on specific sites of histones regulate the balance between 
methylation and demethylation in the cells. Activity of a large group of histone 
demethylases containing Jumonji C-terminal domain depends on the presence of non-
heme iron (Hahn, Bose, Edler and Lengeling, 2008). Several reports show that low levels 
of FXN, an iron chaperone, results in accumulated irons in the mitochondria and depleted 
iron in the other cellular compartments leading to a severe imbalance of iron in FRDA 
cells (Adinolfi, Iannuzzi, Prischi, Pastore, Iametti, Martin, Bonomi and Pastore, 2009; 
Bulteau, O'Neill, Kennedy, Ikeda-Saito, Isaya and Szweda, 2004). This suggests that the 
imbalance of iron in FRDA patients may be associated with the activity of iron-
dependent demethylases responsible for levels of H3K27me3. In FRDA cells, compared 
to controls, I detected significant increase of H3K27me3, histone methylation marks 
potentially affected by iron-dependent histone demethylases such UTX. Indeed, over 
expression of UTX increases expression of FXN mRNA in KYSE180 cancer cells (van 
Haaften, Dalgliesh, Davies, Chen, Bignell, Greenman, Edkins, Hardy, O'Meara, Teague, 
Butler, Hinton, Latimer, Andrews, Barthorpe, Beare, Buck, Campbell, Cole, Forbes, Jia, 
Jones, Kok, Leroy, Lin, McBride, Maddison, Maquire, McLay, Menzies, Mironenko, 
Mulderrig, Mudie, Pleasance, Shepherd, Smith, Stebbings, Stephens, Tang, Tarpey, 
Turner, Turrell, Varian, West, Widaa, Wray, Collins, Ichimura, Law, Wong, Yuen, 
Leung, Tonon, DePinho, Tai, Anderson, Kahnoski, Massie, Khoo, Teh, Stratton and 
Futreal, 2009). Moreover, genome-wide approach reveals that FXN deficiency is 
associated with down regulation of genes involved in DNA packaging and nucleosome 
assembly (Huang, Becker, Whitnall, Rahmanto, Ponka and Richardson, 2009).  
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In an effort to alleviate transcriptional block facilitated by the GAA repeat expansions in 
FRDA patients, dissecting the mechanism of heterochromatin-like structure induced by 
the hyperexpanded GAA repeats is critical for logical design of therapeutic approaches. 
Currently, HDACis are the most promising small molecules that restore FXN 
transcription and alter the chromatin status in the proximity of the GAA repeats, but not 
the promoter region of the FXN gene in FRDA cells (Herman, Jenssen, Burnett, Soragni, 
Perlman and Gottesfeld, 2006). However, the question of either the initial event or the 
cascade of epigenetic changes in the GAA repeats region remains to be addressed. 
Perhaps the hyperexpanded GAA repeats per se or non-B DNA structures facilitated by 
the hyperexpanded GAA repeats employ particular proteins that affect modifications on 
histones in the chromatin environment in the vicinity of the GAA repeats. Moreover, 
paused RNA pol II at the c-Myc gene is observed in the vicinity of a triplex forming 
repeat structure (Belotserkovskii, De Silva, Tornaletti, Wang, Vasquez and Hanawalt, 
2007), suggest that non-canonical DNA structures induced by the hyperexpanded GAA 
repeats might be a primary origin of deficient FXN transcription in FRDA. 
 
In fission yeast and Drosophila, and possibly other eukaryotes, the RNA interference 
(RNAi) pathway is involved in heterochromatin formation (Wassenegger, 2005). 
Endogenous short interfering RNA (siRNA) originates from repetitive sequences such as 
centromeric repeats, transposable elements or rDNA and act as a trigger the RNAi 
pathway (Fagegaltier, Bouge, Berry, Poisot, Sismeiro, Coppee, Theodore, Voinnet and 
Antoniewski, 2009). A genome-wide approach revealed that there are antisense 
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transcripts at the FXN locus in humans (He, Vogelstein, Velculescu, Papadopoulos and 
Kinzler, 2008). Recently, more antisense transcripts (FAST-1) were observed in the 
proximity of TSS of the FXN gene in FRDA cells (De Biase, Chutake, Rindler and 
Bidichandani, 2009). Antisense FXN transcripts can be involved in prompting silencing 
of FXN transcription via RNAi-mediated heterochromatin formation through double 
stranded RNA generated from repetitive DNA sequences. In an effort to assess the 
relative contribution of antisense FXN transcripts in regulation of FXN expression, we 
also performed strand-specific RT-PCR to detect antisense transcription in the FXN 
locus. Unfortunately, we were unable to detect antisense transcripts at the regions 
specified in the previous study, the proximity of TSS of the FXN gene as well as region 
upstream of the GAA repeats (data not shown). Therefore, all FXN transcripts examined 
in this study represent sense FXN RNA transcripts.  
 
, Most diseases assocated with repetitive DNA sequences exhibit distinct patterns of 
repetitive element instability in neuronal as compared to non-neuronal cells (Pearson, 
Nichol Edamura and Cleary, 2005). Indeed, although GAA contractions occur in all 
tissues, expansions occur only in the brain of FRDA patients (Cleary and Pearson, 2003). 
The tissue specificity could contribute to disease progression (Swami, Hendricks, Gillis, 
Massood, Mysore, Myers and Wheeler, 2009). DNA metabolism such as replication, 
repair, recombination and transcription, is important for instability of the repetitive DNA 
unit. Notably, abnormal function of mismatch repair proteins, such as MSH2, is 
associated with GAA instability in yeast (Shishkin, Voineagu, Matera, Cherng, Chernet, 
Krasilnikova, Narayanan, Lobachev and Mirkin, 2009) and in inducible pluripotent stem 
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(iPS) cells from FRDA patients (Ku, Soragni, Campau, Thomas, Altun, Laurent, Loring, 
Napierala and Gottesfeld, 2010). Similar to FRDA, base excision repair factors are 
associated with CTG repeat stability (Liu, Prasad, Beard, Hou, Horton, McMurray and 
Wilson, 2009). Tissue specific levels of these trans-acting factors may contribute to 
increased instability of repetitive DNA sequence in neuronal cells of the patients. Also, 
cis-elements, such as the CTCF DNA binding motif, are associated with tissue and 
developmental specificity of increased repeat instability (Pearson, Nichol Edamura and 
Cleary, 2005). CTCF DNA binding motifs flank numerous genes that contain repetitive 
DNA units and are known to modulate chromatin structure and transcription in several 
neurological disorders (Chang, Zhang, Heath, Galjart, Wang and Milbrandt, 2010; 
Pearson, Nichol Edamura and Cleary, 2005). Methylation of cytosine or mutation of 
CTCF-binding motif at the SCA7 locus inhibits CTCF binding, thereby increasing tissue 
specific repeat instability in SCA7 (CAG repeats) (Libby, Hagerman, Pineda, Lau, Cho, 
Baccam, Axford, Cleary, Moore, Sopher, Tapscott, Filippova, Pearson and La Spada, 
2008). In FRDA, more CTCF occupancy are accompanied with heterochromatinized 
structures at the FXN genes, which lead to transcribe antisense FXN RNAs (De Biase, 
Chutake, Rindler and Bidichandani, 2009). However, distinct levels of CTCF in neuronal 
cells have not yet been reported in neurodegenerative diseases affected by repetitive 
DNA sequences. Moreover, occupancy of CTCF is not correlated with overt transcription 
in mammals (Splinter, Heath, Kooren, Palstra, Klous, Grosveld, Galjart and de Laat, 
2006). This suggests that upstream tissue-specific factors that regulate CTCF may 
contribute to tissue specificity of repeat instability. Methylations at the promoter of the 
BDNF gene, a growth factor that plays important roles in regulating neurogenesis, 
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synaptic plasticity, and neuronal survival, are associated with neurodegenerative 
disorders, including Huntingtons disease (Zuccato and Cattaneo, 2009).  
Hypermethylated CpG residues in the BDNF gene in the cortical neuron in 
neurodegenerative conditions inhibits CTCF binding leading to silence of BDNF 
expression (Chang, Zhang, Heath, Galjart, Wang and Milbrandt, 2010). This report may 
shed light on the mechanistic relationship between pathology of neurodegenerative 
diseases and repeat instability in neuronal cell types.   
 
Moreover, CTCF is associated with chromatin looping and altered histone modifications 
(Splinter, Heath, Kooren, Palstra, Klous, Grosveld, Galjart and de Laat, 2006). I found 
that pausing of RNA pol II occurred at the promoter-proximal region, not the region 
upstream of the GAA repeat at the FXN gene. This phenomenon might suggest looping of 
the chromosome from the TSS to a region upstream of the GAA repeats at the FXN gene 
in FRDA cells. The hyperexpanded GAA repeats influence the looping in FRDA cells, 
thereby affect not only chromatin structure but also FXN transcription. In reconstitution 
assays, nucleosomes are less well assembled into double stranded DNA sequences 
containing longer GAA repeats (Ruan and Wang, 2008).  The hyperexpanded GAA 
repeat that have less nucleosome assembly might have higher opportunity to be looped 
between TSS and the region immediately upstream of the GAA repeats, thereby affecting 
configuration of chromatin structure and distribution of RNA pol II at the FXN gene in 
FRDA cells. 
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Expansions of repetitive DNA sequences are correlated with human neurological and 
neuromuscular diseases. To date, at least 15 neurodegenerative disorders are identified as 
the repeats-expansion diseases (Wells, 1996). These lengths of repetitive DNA unit are 
dynamic in among individuals, generations, and tissues of the patients. There are many 
evidences that these repeat expansion diseases have common epigenetic features such as 
heterochromatin associated histone modifications, the presence of short/antisense RNA, 
and hypermethylated CpG residue, and CTCF binding in the proximity of the repeats (Al-
Mahdawi, Pinto, Ismail, Varshney, Lymperi, Sandi, Trabzuni and Pook, 2008; Cho, 
Thienes, Mahoney, Analau, Filippova and Tapscott, 2005; Filippova, Thienes, Penn, Cho, 
Hu, Moore, Klesert, Lobanenkov and Tapscott, 2001; Pietrobono, Tabolacci, Zalfa, Zito, 
Terracciano, Moscato, Bagni, Oostra, Chiurazzi and Neri, 2005; Verdel, Jia, Gerber, 
Sugiyama, Gygi, Grewal and Moazed, 2004). These similarities in epigenetic pathologies 
on silenced alleles of each repeat expansion diseases suggest similar therapeutic 
approaches to enhance the gene expression in an effort to alleviate disease symptom. 
However, some of features are excluded when epigenetic pathology of each repeat 
expansion disease defines, suggesting that distinct mechanisms responsible for repeat-
mediated chromatin remodeling in each repeat expansion disease may be present. 
Therefore, my study that carefully define chromatin structures adopted by the 
hyperexpanded GAA repeat will help not only understand shared epigenetic features in 
repeat expansion diseases but also distinguish epigenetic features of FRDA from other 
repeats expansion diseases. 
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Chapter 6. Significance and Future Directions 
 
 
 
 
 
 
 
 
 
 
Some parts of this dissertation were modified from the following journal article: 
Eunah Kim, Marek Napierala, Sharon Y.R. Dent. Hyperexpansion of GAA repeats 
affects post-initiation steps of FXN transcription in Friedreich’s ataxia, Nucleic Acids 
Research, (2011) 39(19): 8366-8377. 
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My studies define comprehensive distribution of histone modification at the FXN gene in 
multiple lymphoid cell lines derived from FRDA patients and unaffected controls (Figure 
28). I found that the hyperexpanded GAA repeats influence chromatin structure in the 
regions flanking the GAA repeats, but these differences do not spread to the promoter. 
On the contrary, the levels of RNA pol II and histone methylations representing 
transcription elongation were significantly decreased at the FXN gene in FRDA cell lines. 
These results strongly demonstrate that the transcription machinery is inhibited after 
successful initiating FXN transcription in FRDA cells. Moreover, I first show that RNA 
pol II is predominant at the FXN promoter-proximal region, appears to be paused, in 
unaffected cell lines, but not FRDA cell lines. Comparison of altered H3K4me3 and 
H3K79me2 levels at the FXN gene revealed that FXN deficiency is associated with 
defective efficiency of transition from initiation to elongation of FXN transcription. 
Taken together, my study provides strong indication that FXN insufficiency in FRDA 
patients is caused by a defective transition at a post-initiation step of FXN transcription. 
Perhaps heterochromatin-like structures in the vicinity of the hyperexpanded GAA 
repeats act as an obstacle to produce full length FXN mRNA.  
 
Regulatory elements located in the first intron affect expression of several genes (De 
Jaco, Camp and Taylor, 2005; Lee, Dahi, Mahimkar, Tulloch, Alfonso-Jaume, Lovett and 
Sarkar, 2005). Studies using deletion mapping of the FXN intron 1 revealed that the 
intron 1 is capable of regulating FXN expression (Greene, Mahishi, Entezam, Kumari and 
Usdin, 2007). Results of ChIP assay in this study demonstrate that the intronic region 
upstream of the hyperexpanded GAA repeats exhibit the most significant differences of  
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Figure 28. A summary of distributed histone modifications at the human FXN gene. 
In FRDA cells, the FXN gene enriched with constellation of H3K9me3, H3K27me3, and 
H4K20me3, strongly supporting that the FXN gene in FRDA cells has heterochromatin-
like structures due to possibly the hyperexpanded tract of GAA repeats. This 
phenomenon demonstrated in the GFP_GAA reporter system. H3K4me2, H3K36me3, 
and H3K79me2 associated with euchromatin are decreased at the FXN gene in FRDA 
cells as well as the GFP gene in the GFP_(GAATTC) 560 cells of the GFP_GAA 
reporter system. Distribution of RNA pol II is repressed at the entire FXN gene in FRDA 
cells compared to unaffected cells. RNA pol II seems to be poised at the downstream of 
the transcription start site (TSS) of the FXN gene in unaffected cells, not FRDA cells. 
Although the detailed mechanisms is unclear, heterochromatin-like structure at the 
vicinity of the GAA repeats induced by the hyperexpanded GAA repeats lead to 
consequence of FXN deficiency at the region downstream of the GAA repeats in FRDA 
cells. 
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Figure 28 
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histone modifications between FRDA and control cell lines. The cytosine residue in this 
region is preferentially methylated in FRDA patients (Greene, Mahishi, Entezam, Kumari 
and Usdin, 2007). The levels of DNA methylation proportionally correlate with the 
length of the GAA repeats (Castaldo, Pinelli, Monticelli, Acquaviva, Giacchetti, Filla, 
Sacchetti, Keller, Avvedimento, Chiariotti and Cocozza, 2008). One of the methylated 
cytosine is localized into an E-box motif (CANNTG). The c-Myc, a bHLH transcription 
factor that recognize the E-box motif, interacts with the E-box resided in the region 
upstream of the repeats in P493 cells (Fernandez, Frank, Wang, Schroeder, Liu, Greene, 
Cocito and Amati, 2003). Moreover, the induction of c-Myc is associated with 
enhancement of FXN transcription (Schuhmacher, Kohlhuber, Holzel, Kaiser, Burtscher, 
Jarsch, Bornkamm, Laux, Polack, Weidle and Eick, 2001). Myc proteins allow the 
paused RNA pol II to be released from promoter to activate gene expression (Rahl, Lin, 
Seila, Flynn, McCuine, Burge, Sharp and Young, 2010). c-Myc physically interact with 
components from chromatin modifying/remodeling complexes such as GCN5 to activate 
gene expression  (Flinn, Wallberg, Hermann, Grant, Workman and Wright, 2002; 
Kenneth, Ramsbottom, Gomez-Roman, Marshall, Cole and White, 2007). In the 
unaffected cells, enrichments of H3K4me3, H3K4me2 and H3K79me2 in the region 
upstream of the GAA repeats encompassing E-box motif potentially facilitate binding of 
myc proteins in the E-box. Therefore, hypermethylated DNA sequences in the region 
upstream of the GAA repeats in FRDA cells can influence the interactions between myc 
proteins and the E-box motif (Guccione, Martinato, Finocchiaro, Luzi, Tizzoni, Dall' 
Olio, Zardo, Nervi, Bernard and Amati, 2006; Perini, Diolaiti, Porro and Della Valle, 
2005). My study here emphasizes the region upstream of the repeats is valuable as the 
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regulatory element leading to appropriate FXN transcription. It is likely that epigenetic 
changes in the intron 1 of the FXN gene induced by the hyperexpanded GAA repeats 
interfere with transcriptional enhancers. Subsequently, reduced progression of 
transcriptional machinery result in defective FXN expression in FRDA patients. 
Additionally, c-Myc has been shown to interact with GCN5, an acetyltransferase 
responsible for H3K9/14ac in eukaryotes (Flinn, Wallberg, Hermann, Grant, Workman 
and Wright, 2002; Kenneth, Ramsbottom, Gomez-Roman, Marshall, Cole and White, 
2007). The decreased levels of H3K9/14ac at the region upstream of the GAA repeats in 
FRDA cells might result from failure of GCN5 recruitment at the region upstream of the 
GAA repeats in FRDA cells. Reduced occupancy (or interaction) of C-Myc and GCN5 in 
FRDA cells may lead to reduced recruitment of transcription machinery containing 
RNAPII. This impaired recruitment may result in particular constellation of histone 
methylations marking repressive chromatin structures at FXN gene in FRDA patients as I 
observed. In order to investigate this possibility, distribution of c-Myc and GCN5 could 
be defined by ChIP-seq in the lymphoid cell lines. Unfortunately, there are no appropriate 
antibodies for GCN5 and c-Myc ChIP. Alternatively, distribution of histone modification 
at the FXN gen can be determined in either the absence or over expression of either c-
Myc or GCN5 in lymphoid cell lines. However, the lymphoid cell lines exhibit 
technically low efficiency of transfection. It would take longer time to set a condition to 
optimize transfection activity. Alternatively, other cell lines such as K562 and HEK293T 
cells as general cell lines can be utilized to investigate effect of c-Myc or GCN5 in FXN 
transcription. However, this system will exclude effect of the hyperexpanded GAA 
repeats to understand the roles of c-Myc or GCN5 in FXN transcription. The GFP_GAA 
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system will be a suitable system. However, this system also has limitations that the 
artificial condition in the GFP_GAA system may not be correlated with actual cellular 
function to the heterochromatin-like structure at the FXN gene in FRDA patients. 
Moreover, since several studies suggest that intronic region of the FXN gene have 
regulatory function in FXN transcription, the GFP_GAA system has weakness that have 
non-FXN intronic sequence to regulate either GFP transcription and chromatin structure 
change.  
 
During transcription consisting of series of phase such as initiation, elongation, and 
termination of RNA transcript by RNA pol II, the promoter-proximal pausing of RNAPII 
is a rate-limiting step to produce full-length transcription(Guenther, Levine, Boyer, 
Jaenisch and Young, 2007). I found that levels of RNA pol II is impaired at the promoter-
proximal region of the FXN gene in FRDA cells. More interestingly, the SAGA complex 
that contains GCN5 and the Mediator complex have important roles in inducing 
appropriate levels of gene expression from poised promoters in budding yeast (Lee, 
Fletcher, Zhang, Chen, Fischbeck and Stargell, 2010).  Moreover, c-Myc is involved in 
the release of paused RNA pol II from the promoter-proximal region of a given gene 
(Rahl, Lin, Seila, Flynn, McCuine, Burge, Sharp and Young, 2010). These results raise 
the possibilities that c-Myc bound to the E-box in the region upstream of the GAA 
repeats might be involved in release of paused RNA pol II at the promoter-proximal 
region of the FXN gene.  
 
To further confirm that paused RNA pol II regulates FXN expression, I would examine 
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additional transcription factors, DRB sensitivity-inducing factor (DSIF) and negative 
elongation factor (NELF) as well as P-TEFb using conventional ChIP technique. DSIF 
and NELF are sufficient to stall RNA pol II at the promoter-proximal region of genes 
(Wu, Yamaguchi, Benjamin, Horvat-Gordon, Washinsky, Enerly, Larsson, Lambertsson, 
Handa and Gilmour, 2003). The paused RNA pol II is released from the promoter-
proximal region by phosphorylation of NELF by P-TEFb (Rahl, Lin, Seila, Flynn, 
McCuine, Burge, Sharp and Young, 2010). The P-TEFb is necessary to release the 
paused RNA pol II by phosphorylation of NELF (Peterlin and Price, 2006). Inhibition of 
P-TEFb induces accumulated RNA pol II at the most of genes, suggesting that majority 
of gene is regulated by pausing of RNA pol II (Cheng and Price, 2007; Peterlin and Price, 
2006). C-myc is associated with activation of P-TEFb to release paused RNA pol II 
(Rahl, Lin, Seila, Flynn, McCuine, Burge, Sharp and Young, 2010). Successful release of 
the paused RNA pol II from the promoter-proximal region of genes is necessary to 
elongate full-length transcripts (Saunders, Core and Lis, 2006). Artificial recruitment of 
P-TEFb at the Hsp70 gene under uninduced conditions increases basal Hsp70 expression 
(Lis, Mason, Peng, Price and Werner, 2000). This result suggests that the FXN gene in 
FRDA may have less P-TEFb compared to unaffected controls. To investigate this 
possibility, I could first treat pharmacological inhibitor of P-TEFb in lymphoid cell lines 
followed by ChIP for total RNA pol II at the FXN gene.  
 
Phosphorylation at serine 2 in the CTD of RNA pol II by P-TEFb is indicator of ongoing 
elongation of full-length transcripts (Peterlin and Price, 2006). Unfortunately, I couldn’t 
detect appreciative levels of phosphorylated serine 2 of RNA pol II by conventional 
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ChIP. Instead, nuclear run on assay is possibly able to detect elongating full-length FXN 
transcripts. If paused RNA pol II is associated with regulation of FXN transcription, I 
would detect increased phosphorylated RNA pol II at serine 2 upon the treatment of 
pharmacological P-TEFb inhibitor in FRDA cells.  
 
Levels of H3K9me3 have been less correlated with FXN transcription, suggesting that 
levels of H3K9me3 are not the primary means to induce the heterochromatin-like 
structure facilitated by the GAA repeats. This suggestion allows me to hypothesize that 
hyper DNA methylation at the region upstream of the GAA repeats in FRDA cells is 
associated with altered histone modifications as is observed in my studies. Although the 
relationship between DNA methylation and histone modifications has not been fully 
understood, these two systems may play a part in regulating repressive chromatin 
structures. To investigate the effect of the DNA methylation in FXN transcription as well 
as altered chromatin structure at the FXN gene in FRDA cells, I would examine 
distribution of more histone modifications and total RNA pol II after removal of DNA 
methylation using 5-aza-2-deoxycytidine, an inhibitor of DNA methylation. If there is no 
change in histone modifications, it would further demonstrate that hyper DNA 
methylation in FRDA patients is involved in a different mechanism to silence FXN 
transcription in FRDA patients. If there are changes in histone modifications associated 
with the transcription process after 5-aza-2-deoxycytidine treatments, I will be able to 
determine which step of FXN transcription is affected by high levels of the DNA 
methylation at the region upstream of the GAA repeats in FRDA patients. To further 
demonstrate that the observations after removal of DNA methylation result from the 
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hyperexpanded GAA repeats per se, not either inherent characteristics of the FXN gene, I 
will take advantage of the GFP_GAA system. First of all, I will examine the levels of 
DNA methylation at the region upstream of the GAA repeats in the GFP_GAA cell lines 
to see the expanded GAA repeats induce DNA methylation in the vicinity of the repeats 
using either MS-PCR or bisulphate sequencing. If there are no DNA methylation changes 
in the GFP_GAA cells, one possibility is that the GAA repeats do not induce DNA 
methylations. The histone modification changes by the GAA repeats are primary factors 
to restore FXN transcription in FRDA. Another possibility is that 560 GAA repeats 
insufficient to induce DNA methylation to silence gene expression since the DNA 
methylation is correlated with the length of the GAA repeats in FRDA patients. If the 
GFP_(GAATTC) 560 cells have more DNA methylation compared to the 
GFP_(GAATTC) 0 cells, I should determine which factor between DNA methylation 
and histone modification can be more important/first targets to restore FXN transcription 
by additional experiments.  
 
Although we detected no antisense FXN transcripts at the FXN locus, we cannot exclude 
possibility that there are double strand RNAs originating from the hyperexpanded GAA 
repeats to form RNAi-mediated heterochromatin-like structures at the FXN gene in 
FRDA cells. Moreover, the presence of H3K9me3 overlaps with RNAi-mediated 
heterochromatin formation in fission yeast (Cam, Sugiyama, Chen, Chen, FitzGerald and 
Grewal, 2005). Although I observed significant levels of H3K9me3 at the region 
upstream of the GAA repeat in FRDA cells, I could not detect any isoforms of HP1 
protein. This suggest different pathway to form heterochromatin-like structure at the FXN 
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gene. The argonaute protein is a key player to participate in RNAi-mediated gene 
silencing as part of the RNA-Induced Transcriptional Silencing (RITS) complex 
mediating RNAi pathway to heterochromatin assembly (Buker, Iida, Buhler, Villen, 
Gygi, Nakayama and Moazed, 2007). The identifying small RNAs and proteins 
associated with the RITS complex at the FXN gene in FRDA will determine if the 
hyperexpanded GAA repeat is involved in RNAi-mediated FXN silencing via assembly 
of heterochromatin in FRDA.  
 
Although expansion of the GAA repeats is the primary factor driving chromatin changes, 
the possibilities that metabolic changes resulting from frataxin deficiency in FRDA cells 
contribute to shaping of epigenetic landscape at the FXN gene has not been excluded. 
Frataxin is associated with protestation of cells against cytotoxic stress that might be 
involved in the fine-tuning regulation of FXN expression (Jiralerspong, Ge, Hudson and 
Pandolfo, 2001).  
 
Moreover, HDACi treatments have no association of H3K9me3 levels at the FXN gene in 
FRDA cells in despite of enhancing FXN expression (Herman, Jenssen, Burnett, Soragni, 
Perlman and Gottesfeld, 2006; Punga and Buhler, 2010). This result suggests that 
inhibition of acetylation on non-histone is involved in the regulation of FXN transcription 
as well as chromatin structure changes at the FXN gene in FRDA cells. Therefore, global 
analyses of nucleosome position and histone modifications in FRDA are necessary to 
reveal the full spectrum of epigenetic consequences of reduced frataxin levels. 
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Overall, my study will help to clarify underlying mechanisms of how epigenetic changes 
observed in the vicinity of the hyperexpanded GAA repeats at the FXN gene are 
associated with FXN deficiency in FRDA patients. Furthermore, this study can 
potentially be developed to investigate therapeutic targets (e.g. methyltransferase or 
demethylase responsible for altered histone modifications observed in my studies) for 
curing FRDA.  
 
 
 131 
Figure 29. A working model of heterochromatin-like structure formation at the 
FXN gene in FRDA. 
HDACs are recruited to the FXN gene and remove acetyl group at the N-terminal tail of 
the histones. Histone lysine methyltransferase add methyl group at the N-terminal tail of 
the histones in the vicinity of the hyperexpanded GAA repeats in FRDA cells. According 
to the distribution of RNA pol II in the lymphoid cell lines, the fate of RNA pol II is first 
likely to be determined at the promoter-proximal region (+48 bp) to regulate either FXN 
expression or chromatin structures. At the region upstream of the GAA repeats, RNA pol 
II would be inhibited to elongate FXN transcription through one of mechanisms in 
following, which lead to FXN deficiency in FRDA patients. One is that either non-B 
DNA structure or heterochromatin-like structure induced by the hyperexpanded tract of 
GAA repeats inhibit recruitment of chromatin modifying/remodeling complexes or DNA 
methyltransferase. Another is that methylated CpG residue at the E-box (CACGTG) in 
FRDA inhibits binding of transcription factors such as c-Myc, which lead to low levels of 
RNA pol II and altered histone modifications resulting in FXN deficiency in FRDA. 
Moreover, antisense FXN transcripts from the hyperexpanded GAA repeats in FRDA 
patients can be involved in small RNA-mediated heterochromatin formation. 
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Figure 29 
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